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1. Introduction 
1.1. Reactive oxygen species – a double-edged sword 
The term reactive oxygen species (ROS) defines a group of chemical molecules with at least 
one oxygen atom and with higher reactivity than molecular oxygen. This group consists of highly 
reactive free radicals like the superoxide anion (.O2
-), the hydroxyl radical (.OH) and peroxy 
radicals (.OOR) and nonradical species such as singlet oxygen (1O2), ozone (O3), hypochlorite 
anion (OCl-) and the relatively stable hydrogen peroxide (H2O2). ROS are generated under 
harsh inorganic conditions (e.g. .OOR, O3 and OCl
- in the atmosphere), but are also produced 
by nearly all organisms and cells (Chavez et al., 2009; Niethammer et al., 2009; Pendyala et al., 
2009; Ha et al., 2005; Levine et al., 1994). All cellular ROS sources produce .O2
- by single 
electron transfer to molecular oxygen. .O2
- then acts as precursor of all other cellular ROS 
species (Lambeth et al., 2014; Cheeseman et al., 1993) (Fig. 1). 
 
Figure 1: Major ROS subspecies in organisms (modified from Lambeth et al., 2014) 
All cellular ROS sources produce 
.
O2
-
 by single electron transfer to molecular oxygen.
 .
O2
-
 then acts as precursor of 
all other ROS species. Nitric oxide (NO) and peroxynitrite (ONOO
-
) are not ROS but reactive nitrogen species 
(RNS). The oxidation of 
.
O2
-
 by ferric iron (Fe
3+
) is called Fenton reaction and rarely happens in cells. 
1.1.1. Cellular ROS levels – the quantity makes the poison 
Cellular ROS levels are in a dynamic but stable equilibrium that consists of the sum of all 
producing and eliminating factors in the cell. ROS can be produced as byproducts of oxidative 
metabolic processes (Kelley et al., 2010; Nohl et al., 2003), as a cellular response to foreign 
stimuli such as pathogenic infections (Gluschko and Herb et al., 2018; Schramm et al., 2014; 
Hoeven et al., 2011; West et al., 2011b; Babior, 2002) or intrinsic stimuli such as cytokines 
(Bulua et al., 2011a; Kim et al., 2010). 
Figure 1 
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The antioxidant defense system, which counterbalances excessive ROS production includes 
three superoxide dismutases (SOD1, 2, 3) (decomposition of .O2
- to H2O2) and catalase 
(dismutation of H2O2 to H2O and O2), as the most important components (Poljsak et al., 2013; 
Ha et al., 2005; Fridovich, 1997). SOD1 is localized in the cytosol and the intermembrane space 
of mitochondria (IMS), SOD2 is found exclusively in the mitochondrial matrix and SOD3 is an 
extracellular enzyme (Lambeth et al., 2014; Melov et al., 1999). Catalase is mainly localized in 
organelles called peroxisomes, but is also present in the cytosol and in mitochondria (Kirkman 
et al., 2007). In addition, a pool of soluble (e.g. glutathione in combination with glutathione 
peroxidase) and membranous molecules (e.g. α-tocopherol, coenzyme Q) contribute to ROS 
scavenging (Jones et al., 2016; Poljsak et al., 2013; Schafer et al., 2010). 
Excessive ROS production is often referred to as oxidative stress and associated with damage 
of lipids, proteins and DNA (Lambeth et al., 2014; Diaz et al., 2012; Schumacher et al., 2008; 
Fiers et al., 1999). This ROS-dependent direct damage of cellular molecules can cause a 
number of pathologies (Thimmulappa et al., 2006; Rangasamy et al., 2005; Cross et al., 1987) 
but can be useful when molecular structures of pathogens are targeted and damaged 
(Winterbourn et al., 2013). However, growing evidence suggests that a slight elevation of ROS 
production has important signaling functions during immunological, physiological and biological 
processes (Nathan et al., 2013a; Finkel, 2011; Tai et al., 2009; Reczek et al.). Therefore, 
maintaining the balance between dampening of harmful ROS levels and a sufficient production 
of ROS levels for beneficial processes (e.g. cell signaling and redox regulation) is the major 
function of the antioxidant system (Nathan et al., 2013a) (Fig.2). 
 
Figure 2: Balance of cellular ROS (from Nathan et al., 2013) 
Balancing between dampening of harmful ROS levels and a sufficient production of ROS levels for beneficial 
processes (e.g. cell signaling and redox regulation) is the major function of the antioxidant system. 
Figure 2 
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1.1.2. Cellular ROS sources – professional or accidental ROS production? 
.O2
-, as the precursor of all other ROS, and H2O2, which rapidly dismutates from 
.O2
- 
spontaneously or enzymatically by catalase, are both generated by various cellular sources. 
The enzyme family of NADPH oxidases (Nox) (Lambeth et al., 2014; Bedard et al., 2007) and 
the respiratory electron transport chain (ETC) of mitochondria (West et al., 2011b; Brand, 2010; 
Murphy, 2009) are the major ROS generating systems in many eukaryotic cell types. 
1.1.2.1 The Nox family – ROS professionals 
The regulated production of ROS is the sole function of the members of the Nox enzyme family. 
The family consists of the NADPH oxidases Nox1, Nox2, Nox3, Nox4, Nox5 and the dual 
oxidases Duox1 and Duox2. All isoforms are membrane-bound and transfer electrons from 
NADPH to molecular oxygen generating .O2
- and subsequently H2O2. Nox1, Nox2, Nox3 and 
Nox4 require the membrane-bound subunit p22phox (Nakano et al., 2008; Kawahara et al., 
2005), while Nox5, Duox1 and Duox2 do not, but are activated through calcium binding to their 
EF-hand calcium-binding domain (Lambeth et al., 2007) (Fig. 3). 
 
Figure 3: The Nox family enzymes (modified from Lambeth et al., 2014) 
The family consists of the NADPH oxidases Nox1, Nox2, Nox3, Nox4, Nox5 and the dual oxidases Duox1 and 
Duox2. Different stimuli can trigger ROS production by Nox1, 2 and 3, while Nox4 is constitutively active. Nox5, 
Duox1 and Duox2 are activated by calcium binding through the cytoplasmic EF-hand calcium binding domain. 
The Nox isoforms have multiple functions in a wide range of organisms, organs, tissues and cell 
types, including vasoregulation, hormone synthesis, regulation of gene expression, cell 
proliferation and cell differentiation (Lambeth et al., 2014; Aguirre et al., 2010; Bedard et al., 
2007). In contrast to Nox2, as the predominant source of ROS in phagocytes, which produces 
large quantities of ROS to inactivate invading pathogens (Pollock et al., 1995), the other Nox 
isoforms produce smaller amounts of ROS for modulation of signaling pathways or during 
Figure 3 
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anabolic processes (Carnesecchi et al., 2011; Dikalova et al., 2010; Donko et al., 2010; Gavazzi 
et al., 2006; Banfi et al., 2004). 
1.1.2.2 Mitochondria – ROS only as by-product? 
Mitochondria, as energy generating organelles, produce ROS as a byproduct of respiratory 
activity (Lambeth et al., 2014; Nohl et al., 2003). By shuttling electrons from NADH and FADH2 
through the four complexes I-IV of the ETC, a proton gradient is generated that drives ATP 
production by complex V (Fig. 4). The initial ROS subspecies produced by the mitochondrial 
respiratory chain mainly by complexes I and III is .O2
-. Complex I produces .O2
- into the 
mitochondrial matrix, where it is quickly dismutated by SOD2. Complex III also produces .O2
- 
into the matrix but, moreover, can produce ROS into the IMS of the mitochondrion (Lanciano et 
al., 2013; West et al., 2011b; Murphy, 2009; Fridovich, 1997). Besides their well-known roles as 
ROS- and ATP-generating organelles, mitochondria have important functions as regulators of 
cellular homeostasis (Nomura et al., 2016; Liemburg-Apers et al., 2015; Minton, 2013; Raturi et 
al., 2013) and as signaling platforms (Banoth et al., 2018; Denora et al., 2017; Chandel, 2014; 
Lartigue et al., 2013; Zhou et al., 2011; Seth et al., 2005). 
 
Figure 4: ROS production of the ETC (West et al., 2011) 
By shuttling electrons from NADH and FADH2 through the four complexes I-IV of the ETC and the electron carriers 
coenzyme Q (CoQ) and cytochrome c (Cyt c), a proton gradient is generated that drives (continued on next page) 
 
Figure 4 
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Figure 4 (continued): ROS production of the ETC (West et al., 2011) 
ATP production by complex V. Mitochondria generate ROS mainly by complexes I and III of the ETC. SOD2 and 
glutathione peroxidase (GPX) detoxify ROS in the mitochondrial matrix, while SOD1 and catalase decompose ROS 
in the cytosol. H2O2 can reach the cytosol from the IMS easily by diffusion.
 .
O2
-
 can cross the outer mitochondrial 
membrane only by voltage-dependent anion channels (VDACs). 
1.1.3. ROS as signaling molecules – not always brute force 
The role of ROS as exclusive damaging and toxic molecules, especially for H2O2, is outdated 
and accumulating evidence is growing that ROS act as important signaling molecules in cells 
(Holmström et al., 2014; Lambeth et al., 2014; Nathan et al., 2013a). .O2
- is more reactive than 
H2O2, has a shorter half time and cannot cross membranes without support of channels (e.g. 
VDAC) (Shoshan-Barmatz et al., 2010). Therefore, an increase of .O2
- is often associated with 
oxidative stress and damage. However, some proteins are regulated by irreversible .O2
--
dependent inactivation (Chen et al., 2009). 
H2O2 as a diffusible and, compared to other ROS subspecies, relatively stable molecule is more 
suitable as signaling molecule in cells (Zhang et al., 2016; Marinho et al., 2013). A well 
understood mechanism of H2O2-mediated signaling is the oxidation of cysteine residues (Jones 
et al., 2016; Short et al., 2016; Rhee, 2006; Chiarugi et al., 2001). At physiological pH, the thiol 
groups of cysteines exposed to the cytosol exist in a deprotonated state (Cys-S-) and are 
susceptible to oxidation (Finkel, 2011). H2O2-dependent signaling occurs in a nanomolar 
concentration range (~100 nM), leading to the reversible oxidation of the thiolate group (Cys-S-) 
to a sulfenic group (Cys-SOH) (Fig. 5). 
 
(Legend on next Page) 
Figure 5 
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Figure 5: Oxidation and reduction of cysteine residues by ROS (modified from Holmström et al., 2014) 
At physiological pH, the thiol groups of cysteines exist in a deprotonated state (Cys-S
-
) and are susceptible to 
oxidation. These oxidation steps are reversible by antioxidant enzyme systems and molecules such as glutathion 
(GSH). 
Proteins oxidized by H2O2 often undergo allosterical changes. These changes can result in 
different binding capabilities of substrates, directly inactivate or activate enzymatic functions 
(Kamata et al., 2005; Tonks, 2005; Meng et al., 2002; Lee et al., 1998), or lead to covalent 
linkage with other redox-dependent molecules by disulfide bonds (Cys-S-S-Cys) (Zhou et al., 
2014b; Cote et al., 2013b; Herscovitch et al., 2008a; Tegethoff et al., 2003). Since these 
oxidation steps are reversible by antioxidant enzyme systems, these redox-sensitive molecules 
function as important redox switches during various cellular responses (Holmström et al., 2014; 
Barford, 2004) (Fig. 6). By contrast, excessive H2O2 production leads to further oxidation of the 
sulfenic group to sulfinic (Cys-SO2H) and sulfonic groups (Cys-SO3H), which are irreversible 
and result in protein damage (Winterbourn et al., 2008). 
 
Figure 6: Protein modifications induced by ROS (modified from Holmström et al., 2014) 
Redox-sensitive molecules function as important redox switches during various cellular responses. 
In addition to the different ROS-inducing stimuli, ROS sources, ROS subspecies and their 
specificity and selectivity for their targets, the compartmentalization of ROS production is an 
important factor to determine if damage or redox signaling will occur (Kaludercic et al., 2014; 
Ushio-Fukai, 2009). 
Nox2-dependent ROS production by macrophages, for example, takes place at the plasma 
membrane, damaging invading pathogens, while mitochondria-dependent ROS production is 
dynamically translocated by the organelle to the place where ROS are needed (Al-Mehdi et al., 
2012; West et al., 2011b). .O2
- production into the mitochondrial matrix has other consequences 
than production in the cytosol regarding cellular damage (Fig. 7). Accordingly, SOD2-KO mice 
Figure 6 
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show a more severe pathological phenotype than SOD1-KO mice (Lambeth et al., 2014; Melov 
et al., 1999). Thus, all of these factors that influence ROS production have to be considered 
when new mechanistic insights of ROS-dependent signaling are to be investigated. 
 
Figure 7: ROS production in different subcellular compartments. 
The compartmentalization of ROS production is an important factor to determine, if mechanistic insights of ROS-
dependent functions are investigated. 
1.2. Macrophages – all-rounders at the front line of battle 
Macrophages are cells of the innate immune system and the first line of defense against 
invading pathogens (Epelman et al., 2014; Davies et al., 2013). They engulf bacteria by 
phagocytosis and subsequently kill them by degradation in phagolysosomes (Haas, 2007; 
Djaldetti et al., 2002). To inactivate phagocytosed bacteria, macrophages employ an array of 
directly antimicrobial responses, e.g. the generation of ROS and RNS into the phagosome and 
the delivery of cathepsins and other hydrolases during phagosomal maturation (Mitchell et al., 
2016; Weiss et al., 2015; Schramm et al., 2014; del Cerro-Vadillo et al., 2006; Aktan, 2004; 
Utermohlen et al., 2003; Alvarez-Dominguez et al., 2000). Via indirect antimicrobial 
mechanisms like the secretion of cytokines and chemokines, macrophages help to orchestrate 
the subsequent innate and adaptive immune responses (Arango Duque et al., 2014). 
Figure 7 
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1.2.1. Infection with Listeria monocytogenes – a complicated enemy 
Listeria monocytogenes (L.m.) is a gram-positive, rod-shaped bacterium, which causes severe 
food-borne infections (Radoshevich et al., 2018; Farber et al., 1991). For immunocompromised 
individuals, newborns and pregnant women, L.m. infection is often lethal (Ray et al., 2009; 
McLauchlin et al., 2004; McLauchlin, 1990). After ingestion, L.m. is able to cross the intestinal 
barrier by invading the cells of intestinal epithelial layers. As facultative intracellular bacterium 
(Freitag et al., 2009), L.m can partly escape phagosomal degradation in resident macrophages 
and utilize the cell as a host for replication and as transport vehicle (Pillich et al., 2012). 
Therefore, it is of critical importance that other cells of the innate and adaptive immune system 
are activated and recruited to the sites of infection (Regan et al., 2014; Iwasaki et al., 2010). For 
this purpose, macrophages produce and secrete cytokines and chemokines in response to L.m. 
infection (Arango Duque et al., 2014; Cavaillon, 1994). 
Pro-inflammatory cytokines like IL-6, TNF and IL-1β are necessary for activation of other 
immune cells like neutrophils or, in combination with other signals, for self-activation of 
macrophages enhancing their killing capabilities (Schramm et al., 2014; Yazdanpanah et al., 
2009; Mosser et al., 2008; Harrington-Fowler et al., 1981). After secretion chemokines generate 
a chemotactic gradient, which leads to recruitment of immune cells from the surrounding tissues 
and the blood stream to the site of infection (Arango Duque et al., 2014). 
L.m. is a pathogen that has already been used to unravel numerous immunological processes 
(Mitchell et al., 2016; Pamer, 2004; Goldberg, 2001). L.m. specializes in escaping 
phagolysosomal degradation in macrophages by lysing the phagosomal membrane with its 
pore-forming toxin Listeriolysin O (LLO) (Seveau, 2014; Hamon et al., 2012; Meyer-Morse et al., 
2010; Beauregard et al., 1997). Therefore, recognition of L.m. infection not only involves surface 
pattern recognition receptors (PRR) such as Toll-like receptors (TLRs) (Ley et al., 2016; Regan 
et al., 2014; West et al., 2006), scavenger receptors and C-type lectin receptors (Taylor et al., 
2005) but also intracellular PRR such as NOD-like receptors and RIG-I-like receptors (Motta et 
al., 2015; Hagmann et al., 2013). Moreover, L.m. can also be recognized by a number of 
phagocytic receptors such as opsonic receptors and integrins (Gluschko and Herb et al., 2018; 
Lischke et al., 2013; Ehlers, 2000). One of the consequences of the simultaneous activation of 
these receptors is a robust induction of pro-inflammatory cytokine secretion making L.m. an 
ideal model to study the pro-inflammatory response of macrophages to infection with a bacterial 
pathogen (Fig 8). 
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Figure 8: Receptor repertoire of macrophages (modified from Trinchieri et al., 2007) 
Recognition of L.m. not only involves surface PRR such as TLR but also intracellular PRR such as NOD-like 
receptors and RIG-I-like receptors. Besides receptors that recognize bacterial structures, macrophages also can 
detect fungal cell wall components by the Dectin-1 receptor and viral nucleic acids by RIG-I or MDA5. 
1.2.2 Pro-inflammatory signaling in macrophages – a complicated response 
As described in 1.2., one of the major functions of macrophages during infection is the secretion 
of pro-inflammatory cytokines. The pro-inflammatory response leading to cytokine secretion is 
initiated by complex signaling cascades that culminate in activation of the NF-κB pathway and 
the mitogen-activated protein kinase (MAPK) pathways. The three major MAPK pathways 
initiated upon infection finally result in the activation of the MAPKs p38, JNK1/2 and ERK1/2 
(Arthur et al., 2013; Newton et al., 2012; Kawai et al., 2011). 
Upon infection with a gram-positive pathogen like L.m., this signaling cascade is mostly initiated 
by receptor heterodimers of TLR2-1 and TLR2-6 that recognize cell wall components of gram-
positive bacteria (O'Neill et al., 2013; Newton et al., 2012). TLR2 directly engages the adaptor 
Figure 8 
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protein MyD88 (Lee et al., 2015; Adachi et al., 1998), which mediates interactions with the 
serine/threonine kinases IRAK4 and IRAK1/2 (Lin et al., 2014). The MyD88-IRAK4/1/2 complex 
then recruits the E3 ubiquitin ligase TRAF6, which catalyzes formation of K36 polyubiquitin 
chains on both TRAF6 itself and IRAK1/2 (Tenekeci et al., 2016; Zhang et al., 2010; Skaug et 
al., 2009). Recruitment of the kinase TAK1 along with its adaptor proteins TAB2/3 (Kanayama 
et al., 2004; Ishitani et al., 2003) to K36 polyubiquitinated TRAF6 triggers TAK1-mediated 
activation of the p38 and JNK1/2 MAPK pathways (Israel, 2010; Sato et al., 2005; Shim et al., 
2005). TAK1 is not an obligatory general kinase of this complex but more a regulatory 
modulator that is activated in a cell-type and stimulus-specific manner (Hinz et al., 2014; 
Ajibade et al., 2012; Liu et al., 2012). In macrophages, the ERK1/2 pathway and the NF-κB 
pathways are activated TAK1-independently by the IKK complex (Ajibade et al., 2012; Gantke 
et al., 2012; Mercurio et al., 1997). The IKK complex consists of the kinase subunits IKKα 
(IKK1) and IKKβ (IKK2) and the regulatory subunit IKKγ (NEMO) (referred to as NEMO in this 
thesis) (Israel, 2010) (Fig.9). 
 
(Legend on next page) 
Figure 9 
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Figure 9: The activation of NF-κB and the MAPK pathways (modified from Arthur et al., 2013) 
The pro-inflammatory response leading to cytokine secretion is initiated by complex signaling cascade that 
culminates in activation of the NF-κB pathway and the MAPK pathways. TRAF6 can also be induced independently 
from the IRAK1/2/4 complex by binding to TRAF2 and ASK1. 
NEMO is of particular importance for IKK complex activation as it regulates both, activity and 
substrate interactions of IKKα and IKKβ (Maubach et al., 2017; Hinz et al., 2014; Clark et al., 
2011). Several studies described different possible oligomeric structures of NEMO such as 
dimers, trimers or tetramers (Herscovitch et al., 2008a; Marienfeld et al., 2006; Agou et al., 
2004; Tegethoff et al., 2003). The primary functional unit of the IKK complex is a constitutive, 
non-covalently linked dimer of NEMO associated with a homo- or heterodimer of IKKα/β (Zhou 
et al., 2014a; Cote et al., 2013a). In resting cells, these minimal functional units are organized 
via direct interactions and binding of NEMO to ubiquitin chains into higher-order lattice-like 
structures (Scholefield et al., 2016). In response to pro-inflammatory stimuli, NEMO reorganizes 
from these lattice-like structures into condensed supramolecular complexes (Scholefield et al., 
2016). The NEMO complexes undergo further polyubiqutination and bind to polyubiquitin chains 
on the pre-formed TLR/MyD88/TRAF6 complex (Tarantino et al., 2014; Arthur et al., 2013; 
Tokunaga et al., 2012; Laplantine et al., 2009; Rahighi et al., 2009; Windheim et al., 2008; Wu 
et al., 2006a; Tang et al., 2003; Deng et al., 2000). 
In addition to ubiquitination and supramolecular rearrangements, NEMO can be modulated by 
various other post-translational modifications such as phosphorylation (Palkowitsch et al., 2008; 
Wu et al., 2006b; Carter et al., 2003; Prajapati et al., 2002) or SUMOylation (Lee et al., 2011; 
Mabb et al., 2006; Huang et al., 2003). However, despite the strict dependency of NEMO for 
several downstream signaling pathways, the exact roles of NEMO in the signaling complex are 
not fully understood (Liu et al., 2012; Israel, 2010; Shifera, 2010). So far, a function as 
scaffolding protein that mediates binding and organization of up- and downstream signaling 
components is well established (Schrofelbauer et al., 2012; Clark et al., 2011; Chariot et al., 
2002; Harhaj et al., 1999; Rothwarf et al., 1998). All of the studies that investigated NEMO 
function and structure used either ligands that activate only one specific signaling pathway (e.g. 
TNF, IL-1β, LPS) (Scholefield et al., 2016; Xu et al., 2009; Herscovitch et al., 2008a; Windheim 
et al., 2008; Marienfeld et al., 2006; Tang et al., 2003; Chen et al., 2002; Cooke et al., 2001) or 
investigated the response of non-immune cells (e.g. HeLa cells, porcine kidney cells, HEK 293T 
cells) to infection (Brady et al., 2017; de Jong et al., 2016; Wang et al., 2012; Soundararajan et 
al., 2011; Ashida et al., 2010). Therefore, the structural and post-translational modifications as 
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well as the role of NEMO during bacterial infection in immune cells in general or in 
macrophages in particular remain elusive. 
Initiation and assembly of a functional TLR/MyD88/TRAF6/NEMO complex leads to activation of 
IKKα/β by phosphorylation (Polley et al., 2013). Phosphorylated IKKβ then directly induces 
ubiquitin-mediated degradation of the inhibitory subunits p105 (ERK1/2 pathway) and IkBα (NF-
κB pathway) (Kanarek et al., 2012; Li et al., 1999; Brown et al., 1995; Traenckner et al., 1995). 
p105, together with ABIN2, releases the kinase TPL2 that initiates a phosphorylation cascade 
resulting in activation of ERK1/2 (Gantke et al., 2012; Beinke et al., 2004; Waterfield et al., 
2004) (Fig. 9). IκBα sequesters NF-κB in the cytosol and its degradation releases NF-kB. 
Activation of the ERK1/2 and NF-κB pathways lead to nuclear translocation and/or activation of 
transcription factors that are crucial for the pro-inflammatory response (Newton et al., 2012). 
Regulation of this response to individual PAMPs such as LPS (gram-negative) or lipoteichoic 
acid (gram-positive) that stimulate individual TLR signaling pathways has been extensively 
studied (Kawai et al., 2011; Hambleton et al., 1996). However, again, much less is known about 
the response to complex stimuli such as pathogenic bacteria that simultaneously activate 
multiple signaling pathways. 
1.2.3 ROS production in macrophages – with the license to kill 
Recognition of pathogens by macrophages leads to a substantial and fast increase of ROS 
production into the extracellular space and into the phagosome (Gluschko and Herb et al., 
2018; Craig et al., 2009). This rapid increase of ROS accompanied by elevated oxygen 
consumption is known as the respiratory burst. It is catalyzed by Nox2, the predominant and 
well-characterized ROS source in phagocytes including macrophages (Babior, 2002). 
Nox2 consists of two membrane bound subunits, gp91phox and p22phox that form the catalytic 
unit, named flavocytochrome b558, three cytosolic subunits (p40
phox, p47phox, p67phox) and the 
small GTPase Rac1 (Fig 10) (Kawahara et al., 2005; Ago et al., 2003; Ito et al., 1995). Different 
chemical and biological stimuli (e.g. pathogenic infection) result in translocation of p67phox to the 
flavocytochrome b558 guided by p40
phox and/or p47phox. p67phox and Rac1 then mediate electron 
transfer from NADPH to the prosthetic groups of gp91phox (FADH2 and two hemes). gp91
phox 
finally transfers the electrons to molecular oxygen forming .O2
- (Haslund-Vinding et al., 2017; 
Bedard et al., 2007). Several studies have shown that a functional and active Nox2 and the 
subsequently produced ROS are crucial players in anti-microbial immunity (Gluschko and Herb 
et al., 2018; Herb et al., 2018; Singel et al., 2016; Schramm et al., 2014; Leto et al., 2009). 
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Figure 10: Activation and ROS production by Nox2 (adapted from Lambeth et al., 2004) 
Different chemical and biological stimuli, including pathogenic infections result in the activation of Nox2, which 
requires recruitment of the cytosolic subunits p40
phox
, p47
phox
, p60
phox
 and activation of the small GTPase Rac1 
(RAC-GTP). Rac1 is released from its inhibitor Rho GDP dissociation inhibitor (RhoGDI) after exchange of GDP 
with GTP by different guanine exchange factors (GEF). Nox2 activation also needs membrane lipid remodelling. 
Phosphatidylinositol 3 kinase (PI3K) adds a phosphate group to phosphatidylinositol diphosphate (PtdInsP2), which 
is necessary for re-organization of the Nox2 subunits p22
phox
 and gp91
phox
. Finally, fully active Nox2 produces ROS 
into the extracellular space. 
For a long time, it was generally accepted that mitochondria, as energy generating organelles, 
produce ROS only as an “accidental” by-product of respiratory activity and increased 
mitochondrial ROS production was only seen in a harmful context (Yang et al., 2016; Li et al., 
2013; Yuan et al., 2013; Dillin et al., 2002). However, several studies have shown that 
mitochondrial ROS production can be actively triggered and increased by macrophages upon 
recognition of bacteria or bacterial PAMPs (Zorov et al., 2014). Furthermore, this increased 
mitochondrial ROS production is necessary for direct antimicrobial host defense (Garaude 
(Garaude et al., 2016; West et al., 2011b) (Fig. 11). 
Figure 10 
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Figure 11: Mitochondrial ROS production is necessary for direct antimicrobial host defense (adapted from 
West et al., 2011). 
Mitochondrial ROS production into the phagosome is actively triggered via relocation of ECSIT/TRAF6 to complex I 
of the ETC after recognition of gram-negative bacteria. The mitochondrial ROS production has been shown to be 
necessary for bacterial clearance. 
1.3 ROS in pro-inflammatory signaling – a nearly blank paper 
The direct anti-bacterial role of Nox2-derived as well as mitochondrial ROS against invading 
bacteria was shown in several studies (Gluschko and Herb et al., 2018; Garaude et al., 2016; 
Schramm et al., 2014; Roca et al., 2013; West et al., 2011b; Arsenijevic et al., 2000). However, 
the role of ROS in the pro-inflammatory response of macrophages to pathogenic bacteria in 
general or infection with L.m. in particular is incompletely understood (Brune et al., 2013; 
Forman et al., 2002). 
Deficiency for Nox2 and Nox2-dervied ROS not only leads to severe immunodeficiency but also 
influences MHC-dependent antigen presentation and leads to a hyper-inflammatory response 
accompanied by elevated cytokine levels (Allan et al., 2014; Rieber et al., 2012). The lack of 
ROS-mediated inactivation of cathepsins has been suggested as a possible mechanism during 
both processes (Allan et al., 2014; Deffert et al., 2012). 
Figure 11 
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If and how mitochondrial ROS contribute to pro-inflammatory signaling in macrophages remains 
an open question as several studies have come to different, sometimes contrasting conclusions 
(Kelly et al., 2015; Bulua et al., 2011a; Zhou et al., 2011; Chandel et al., 2000). Inactivation of 
redox-sensitive phosphatases has been suggested as ROS-dependent regulatory step (Bulua 
et al., 2011a; Meinhard et al., 2001). Nearly nothing is known about the role of mitochondrial 
ROS during pro-inflammatory signaling in infected macrophages, since all of the studies that 
investigated this topic used either PAMP such as LPS or intrinsic molecules such as TNF that 
activate only one distinct signaling pathway. In particular, the underlying molecular mechanisms 
by which mitochondrial ROS may regulate pro-inflammatory signaling and cytokine secretion 
upon bacterial infection have remained completely elusive. 
1.4. Aims of this study 
The aim of this thesis is to investigate if and how Nox-derived and/or mitochondrial ROS 
regulate the pro-inflammatory response during bacterial infection and to identify the ROS-
dependent molecular mechanisms involved in this process. 
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2. Materials & Methods 
2.1. Animals, bacteria, materials 
2.1.1 Mice 
Mice were heterozygously backcrossed to the C57BL/6 strain at least to the 10th generation. 
Animals were bred under specific pathogen-free conditions at the animal facilities of the Medical 
Centre of the University of Cologne (Cologne, Germany). Homozygous transgenic knock-out 
mice and corresponding wild-type littermates, six to ten weeks old, were used for experiments. 
All experiments were performed in accordance with the Animal Protection Law of Germany in 
compliance with the Ethics Committee at the University of Cologne. 
Nox1-/- mice 
Breeding pairs of mice deficient for Nox1 (Gavazzi et al., 2006) were kindly provided by K.-H. 
Krause (Department of Pathology and Immunity, Université de Genève, Geneva). 
Nox2-/- mice 
Breeding pairs of mice deficient for the Nox2 subunit gp91phox (Pollock et al., 1995) were kindly 
provided by R. Brandes (Institute for Cardiovascular Physiology, University Hospital Frankfurt, 
Frankfurt). 
Nox4-/- mice 
Breeding pairs of mice deficient for Nox4 (Carnesecchi et al., 2011) were kindly provided by R. 
Brandes (Institute for Cardiovascular Physiology, University Hospital Frankfurt, Frankfurt). 
p22phox-/- mice 
Breeding pairs of mice deficient for the catalytic subunit of Nox1-Nox4 p22phox (Nakano et al., 
2008) were kindly provided by J. Woo (Dept of Cardiothoracic Surgery, Stanford University 
Medical Center, Stanford). 
Duox1-/- mice 
Breeding pairs of mice deficient for Duox1 (Donko et al., 2010) were kindly provided by M. 
Geiszt (Institute for Physiology, Semmelweis University, Budapest). 
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Duox2-/- mice 
Breeding pairs of mice deficient for Duox2 (Johnson et al., 2007) were purchased from the 
Jackson Laboratory (USA). 
TLR2-/- mice 
Breeding pairs of mice deficient for TLR2 (Wooten et al., 2002) were purchased from the 
Jackson Laboratory (USA). 
MyD88-/- mice 
Breeding pairs of mice deficient for MyD88 (Adachi et al., 1998) were kindly provided by M. 
Pasparakis (University of Cologne, Cologne). 
TRAF6MYEL-KO mice 
Breeding pairs of TRAF6fl/fl/LysMCre+/- (Imai et al., 2008) mice were kindly provided by M. 
Pasparakis (University of Cologne, Cologne). 
Mitochondrial Catalase knockin (mCAT-KI) mice 
Breeding pairs of mice with a mitochondrial catalase knock-in (Schriner et al., 2005) were 
purchased from the Jackson Laboratory (USA). 
TNF-/- mice 
Breeding pairs of mice deficient for TNF (Adachi et al., 1998) were kindly provided by S. 
Nedoskasov (German Rheumatism Research Center, Berlin). 
2.1.2 Bacteria 
Wild-type L. monocytogenes, strain EGD, serotype 1/2a was kindly provided by C. Knocks 
(Harvard Medical School, Boston, USA). The isogenic Δhly- and ΔprfA-deletion mutants of L. 
monocytogenes (Peters et al., 2003) were kindly provided by E. Domann (University of Giessen, 
Germany). The wild-type B. subtilis subsp. spizizenii strain and E.coli K12 DH5-alpha strain 
were purchased from the DSMZ (DSM 6405). Single colonies of strains were expanded in BHI 
medium at 37 °C and 220 rpm until log-phase growing. Aliquots of cultures were stored in 
DMSO at -80 °C for long term storage. 
2.1.3 Chemicals and additives 
Chemicals were of research grade and stored at 2-8 °C as not stated otherwise. All stock 
solutions were prepared in H2O (aqua ad iniectabilia) or H2Obidest from an EASYpure UV/UF 
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H2O purification unit (Werner Reinstwassersysteme, Leverkusen) and sterilized by filtration by 
using a 0.2 µm filter as not further indicated. 
Table 1: List of Chemicals and additives (continued on next page) 
Name Stock solution/Manufacturer 
[γ-P32]ATP Hartmann Analytic 
2-Propanol Carl-Roth GmbH & Co. KG, stored at RT 
5,6-Dicarboxy-2',7'-dichlorodihydrofluorescein 
diacetate, di(acetoxymethyl ester) 
20 mM Stock in DMSO, Thermo Scientific, 
stored at -20 °C 
Acrylamide 4K-Solution Mix (40 %) AppliChem 
Agarose Biobudget Technologies GmbH, stored at RT 
Antimycin A 30 mM Stock in DMSO, Sigma-Aldrich, stored at -20 °C 
APS Sigma-Aldrich 
Benzonase® Nuclease Merck Millipore, stored at -20 °C 
Bromphenol blue Sigma-Aldrich, stored at RT 
BSA Fraction V Sigma-Aldrich 
Calyculin A Merck Millipore, stored at -20 °C 
CCCP 100 mM, Sigma-Aldrich, stored at -20 °C 
CD11b Micro beads (human, mouse) Miltenyi Biotec 
DAPI Sigma-Aldrich, stored at -20 °C 
Deoxycholic acid Sigma-Aldrich 
DEPC Sigma-Aldrich 
Dithiothreitol Sigma-Aldrich 
DMSO Merck Millipore, stored at RT 
EDTA Carl Roth GmbH & Co. KG, stored at RT 
EGTA Carl Roth GmbH & Co. KG. stored at RT 
FCS Biowest AG 
Glycerol AppliChem, stored at RT 
HCl Carl-Roth GmbH & Co. KG, stored at RT 
HiMark™ Pre-stained Protein Standard Thermo Scientific, stored at -20 °C 
Horseradish Peroxidase 400 U/ml in HBSS, Merck Millipore, stored at -20 °C 
Innovative Grade US Origin CD-1 Mouse Complement Dunn Lab, stored at -20 °C 
Isoluminol 50 mM Stock, Sigma-Aldrich, stored at RT 
LCS-1 Calbiochem, stored at -20 °C 
LumiGLO Reserve Chemiluminescent substrate KPL Inc 
Malonate 100 mM Stock, Sigma-Aldrich, stored at -20 °C 
Milk powder Carl Roth GmbH & Co. KG 
Mito-TEMPO 50 mM Stock in DMSO, Sigma-Aldrich, stored at -20 °C 
MOPS Sigma-Aldrich 
Na-Acetat Merck-Millipore 
N-Acetylcysteine  500 mM Stock in PBS pH 7.4, Sigma-Aldrich 
NaCl AppliChem 
Na-orthovanadate Merck Millipore, stored at -20 °C 
Na-Pyruvate (100 mM) Biochrom AG 
Nonidet P40 (NP40) Sigma-Aldrich 
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Okadaic acid Merck Millipore, stored at -20 °C 
PageRuler Prestained Protein Ladder Thermo Scientific, stored at -20 °C 
Paraformaldehyde Merck Millipore 
PD98059 Merck Millipore, stored at -20 °C 
Phosphatase Inhibitor Cocktail Tablets (PhosSTOP) Roche Lifescience, stored at -20 °C 
PMA 6 µg/ml Stock in DMSO , Sigma-Aldrich, stored at -20 °C 
Poly(dI:dC) Roche 
Polynucleotide kinase Roche, stored at -20 °C 
ProLong Gold antifade reagent Invitrogen, stored at -20 °C 
Protease Inhibitor Cocktail Tablets (cOmplete) Roche Lifescience, stored at -20 °C 
PTP-Inhibitor I Merck Millipore, stored at -20 °C 
Rotenone 50 mM Stock in DMSO, Sigma-Aldrich, stored at -20 °C 
Sanguinarine Sigma-Aldrich, stored at -20 °C 
Saponin from quillaja bark Sigma-Aldrich, stored at RT 
SDS AppliChem 
Tautomycin Merck Millipore, stored at -20 °C 
TEMED AppliChem 
TMRE 50 mM in DMSO, Invitrogen, stored at -20 °C 
Tris Th. Geyer GmbH & Co. KG, stored at RT 
Triton X-100 Sigma-Aldrich, stored at RT 
Tween-20 AppliChem, stored at RT 
Ultrapure LPS from E. coli O111:B4 5 mg/ml Stock, Invivogen, stored at -20 °C 
β-mercaptoethanol (98 %) Merck Millipore, stored at RT 
 
2.1.4 Buffers, solutions and media 
All buffers and solutions were prepared with deionized water (H2Obidest) and sterilized by either 
autoclavation or sterile filtration using 0.2 µm filters. All liquids were stored at 2-8 °C as not 
indicated otherwise. 
Table 2: List of Buffers, solutions and media (continued on next pages) 
Name Chemcial composition/Manufacturer 
Aqua ad iniectabilia Delta-Pharma, Inc. 
AT-Lysis buffer 20 mM HEPES, 150 mM NaCl, 1 % Triton X-100, 20 % 
Glycerol, 1 mM EDTA, 1mM EGTA, 20 mM NEM, pH 
7.4, stored at RT 
BHI medium Beckton Dickinson GmbH 
Blocking buffer (Microscopy) 3 % BSA in PBS 
Blocking buffer (Western Blot) 5 % BSA in TBS-T, stored at -20 °C 
Dulbeccos MEM (1X) Biochrom AG 
EDTA solution 0.2 M EDTA in PBS, stored at RT 
EGTA solution 0.2 M EGTA in PBS, stored at RT 
EMSA binding buffer 5 mM HEPES (pH 7.8), 5 mM MgCl, 50 mM KCl, 5 mM 
DTT, 10 % glycerol 
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EMSA buffer A 10 mM HEPES, 10 mM KCl, 0.1 mM EDTA, 0.1 mM 
EGTA, for usage add 1 mM DTT and 1 mM PMSF 
EMSA buffer C 20 mM HEPES, 0.4 mM NaCl, 1 mM EDTA, 1 mM 
EGTA 
FACS Fix solution 2.5 % formaldehyde, 1 % FCS in PBS, stored at RT 
Formaldehyde buffer (10X) 200 mM MOPS, 50 mM Na-Acetat, 10 mM EDTA in 
DECP-treated RNAse-free H2Obidest, pH 7.0 
Formaldehyde solution (37 %) Carl Roth GmbH & Co. KG, stored at RT 
H2O2-Solution (30 %) Sigma-Aldrich 
HBSS (1X, with Ca
2+
, with Mg
2+
, no phenol red) Life Technologies 
HEPES buffer (1 M) Biochrom AG 
Laemmli buffer (5X) (Non-reducing Western Blot) 30 mM Tris/HCL, 12.5 % Glycerol, 1 % SDS, 0.01 % 
bromphenol blue, stored at -20 °C 
Laemmli buffer (5X) (Standard Western Blot) 60 mM Tris-HCl, 25 % Glycerol, 10 % β-
mercaptoethanol, 2 % SDS, 0.2 % bromphenol blue, 
stored at -20 °C 
MACS buffer 0.5 % BSA, 200 mM EDTA in PBS 
NaCl lysis buffer (0.2 %) 0.2 % NaCl in H2O 
NaCl lysis buffer (1.6 %) 1.6 % NaCl in H2O 
NEM 20 mM in 99.8 % Ethanol ROTIPURAN®, 
stored at -20 °C 
NP40 solution 10 % NP40 in PBS 
Paraformaldehyde solution 3 % PFA in PBS pH 7.4, stored at -20 °C 
PBS Dulbecco (1X, pH 7.4) Biochrom AG 
RIPA buffer 150 mM NaCl, 50 mM TrisHCl, 1 % SDS, 0.5 % NP40, 
0.1 % deoxicolic acid, stored at RT 
RNA loading buffer (5X) 16 µL saturated bromphenol blue solution, 4 mM 
EDTA, 720 µL formaldehyde solution (37 %), 20 % 
glycerol, 3.084 ml formamide solution, 4 mL 
formaldehyde buffer (10X) in 10 mL DECP-treated 
RNAse-free H2Obidest  
Roti-Blot A anode buffer (10X) Carl Roth GmbH & Co. KG, stored at RT 
Roti-Blot K cathode buffer (10X) Carl Roth GmbH & Co. KG, stored at RT 
Running buffer (RNA gel) 50 ml formaldehyde buffer (10X), 10 ml formaldehyde 
solution (37 %) in 440 ml DECP-treated RNAse-free 
H2Obidest 
Saponin blocking buffer 0.1 % Saponin, 3 % BSA in PBS 
Saponin washing buffer 0.1% Saponin in PBS 
TAE buffer (50X) 2 M Tris-acetate, 50 mM EDTA, pH 8.5 
TBE buffer (10X) 0.89 mM boric acid, 20 mM EDTA, pH 8.5 
TBS (10X) 150 mM NaCl, 10 mM Tris-HCl, pH 7.4, stored at RT 
TBS-T 0.1 % Tween 20 in 1X TBS, stored at RT 
TGS buffer (10X) (running buffer) Bio-Rad Laboratories, Inc, stored at RT 
Tris-HCl buffer (0.5 M and 1.5 M) Bio-Rad Laboratories, Inc, stored at RT 
Trypan blue solution (1X) Sigma-Aldrich, stored at RT 
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2.1.5 Antibodies 
Table 3: List of antbodys 
Antigen Specification Manufacturer 
β-actin IgG Monoclonal mouse-anti-β-actin antibody Sigma-Aldrich 
CD11b IgG Rat-anti-mouse CD11b antibody, APC-conjugated BD Biosciences 
CD16/CD32 IgG Rat-anti-mouse CD16/32 (mouse Fc receptor block) BD Biosciences 
F4/80 IgG Anti-mouse F4/80 antibody, PE-conjugated eBioscience 
L. monocytogenes Polyclonal rabbit anti-L. monocytogenes antibody US Biologicals 
Mouse IgG Goat-anti-mouse antibody, HRP-conjugated Sigma-Aldrich 
Rabbit IgG Goat-anti-rabbit antibody,  
AlexaFluor 405-conjugated 
Molecular Probes 
Rabbit IgG Goat-anti-rabbit antibody,  
AlexaFluor 488-conjugated 
Molecular Probes 
Rabbit IgG Goat-anti-rabbit antibody,  
AlexaFluor 568-conjugated 
Molecular Probes 
Rabbit IgG Goat-anti-rabbit antibody, HRP-conjugated Sigma-Aldrich 
NF-κB p65 (F-6) 
(Microscopy) 
Monoclonal mouse-anti-NFκB p65 antibody Santa Cruz Biotechnology, Inc. 
FLAG (Microscopy) Monoclonal mouse-anti-FLAG antibody Sigma-Aldrich 
FLAG (Western Blot) Monoclonal mouse-anti-FLAG antibody Cell Signaling Technology 
NEMO/IKKγ Monoclonal mouse-anti-IKKγ antibody Invitrogen 
IRAK1 Monoclonal rabbit-anti-IRAK1 antibody Cell Signaling Technology 
Phospho-IKKα/β 
(Ser176/180) 
Monoclonal rabbit-anti-phospho-IKKα/β antibody Cell Signaling Technology 
IκBα IgG Polyclonal rabbit-anti-IκB-α antibody Santa Cruz Biotechnology, Inc. 
Phospho-NF-κB p65 
(Ser536) IgG 
Monoclonal rabbit-anti-phospho-NF-κB p65 antibody Cell Signaling Technology 
Phospho-SAPK/JNK 
(Thr183/Tyr 185) 
Polyclonal rabbit-anti-phospho-IKKα/β antibody Cell Signaling Technology 
Phospho-MEK1/2 
(Ser217/221) 
Polyclonal rabbit-anti-phospho-IKKα/β antibody Cell Signaling Technology 
Phospho-ERK1/2 Polyclonal rabbit-anti-phospho-ERK1/2 antibody Cell Signaling Technology 
Phospho-p38 
(Thr180/Tyr182) IgG 
Monoclonal rabbit-anti-phospho-p38 antibody Cell Signaling Technology 
 
2.1.6 Molecularbiological materials, constructs and primers 
Table 4: Molecularbiological materials, constructs and primers (continued on next page) 
Material/Construct/Primer Sequence Manufacturer 
5mCTP  Jena Biosience,  
stored at -20 °C 
Antarctic phosphatase  New England BioLabs, 
stored at -20 °C 
FastDigest XbaI  Thermo Scientific 
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GelRed™  Biotium 
Mutant IKKβ IKK-2
S177/181E 
construct Cat#: 11104 Addgene, stored at -20 °C 
Mutant NEMO
C54/347A 
construct Cat#: 27268 Addgene, stored at -20 °C 
O’GeneRuler™ 1 kb DNA Ladder  Thermo Scientific 
Orange DNA Loading Dye (6X)  ThermoScientific 
Pseudo-UTP  Jena Biosience,  
stored at -20 °C 
Q5® High-Fidelity DNA-Polymerase  New England Biolabs Inc 
ssRNA ladder  NewEngland Biolabs 
T7-Promotor forward primer 5-
GAAATTAATACGACTCACTATAGGGTT
GATCTACCATGGACTA-CAAAGACG-3 
XXX, stored at -20 °C 
T7-Promotor reverse primer  5-GAGGAAGCGAGAGCTCCATCTG-3 XXX,stored at -20 °C 
Wild type control IKKβ IKK-1 construct Cat#: 11103 Addgene, stored at -20 °C 
Wild type control NEMO construct  Addgene, stored at -20 °C 
 
2.1.7 PCR programs 
Table 5: PCR programs 
Program/reaction step Temperature (°C) Time (s) 
T7-Promotor PCR   
                       Initial denaturation 98 30 
                       Denaturation 98 10 
30 Cycles       Annealing 56 20 
                       Elongation 72 120 
Final elongation 72 180 
Standby 4 ∞ 
 
2.1.8 Consumable materials 
Table 6: Consumable materials (continued on next page) 
Name Manufacturer 
96F Non-treated Microwell SI (white, black) Thermo Scientific, Nunc 
Amersham ECL hyperfilm GE Healthcare 
BD Microlance 3 Needles (Nr.1, 14, 20) Beckton Dickinson GmbH 
Blood agar plates (sheep) Oxoid Deutschland GmbH 
Cover glass (Ø 13 mm) VWR International 
Criterion Empty Cassettes Bio-Rad Laboratories, Inc. 
FACS tubes (5 ml) BD Biosciences 
Falcon tubes (15, 50 ml) Greiner Bio-One 
Microscope slides Engelbrecht 
MS MACS Separation Columns (LS) Miltenyi Biotec 
Omnifix Syringes (5, 10 ml) B. Braun 
Parafilm American National Can 
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Pipette tips (5, 10, 25 ml) Sarstedt 
Prot/Elec Tips (gel loading) Bio-Rad Laboratories, Inc. 
Tissue Culture Test plates (6-, 12-, 24-, 96F-, 96U-Well) TPP 
Whatman 3MM filter paper GE Healthcare 
Whatman Nitrocellulose membrane GE Healthcare 
 
2.1.9 Technical equipment and devices 
Table 7: Technical equipment and devices (continued on next page) 
Device Specification Manufacturer/Distributor 
Balance Sartorius L2200P Gemini B. V. 
Cell counting chamber Neubauer Improved LO Laboroptik 
Centrifuges Heraeus Multifuge 4KR Thermo Scientific 
 Eppendorf 5417R Thermo Scientific 
ChemiDoc ChemiDoc™ Imaging System Bio-Rad Laboratories, Inc. 
Developer Curix AGFA 
Diaphragm vacuum pump Vacuubrand Bachofer Labor Geräte 
EasyCool™ Beer Cooling Device EasyCool 1.0 Gluschko Bioresearch, Inc. 
Electrophoresis cell Criterion cell Bio-Rad Laboratories, Inc. 
Flow cytometer FACSCalibur BD Biosciences 
Fluorescence microscope (confocal) IX81 Olympus 
Gel electrophoresis chamber  Bio-Rad Laboratories, Inc. 
H2O purification unit EASYpure UV/UF Werner Reinstwassersysteme 
Incubator (bacteria) Kelvitron T Heraeus Instruments GmbH 
Incubator (cells) Hera Cell 240 Heraeus Instruments GmbH 
Incubator shaker Innova 4200 New Prunswick Scientific 
Laminar flow hood HERAsafe Thermo Scientific 
 HERAsafe KS Thermo Scientific 
Magnetic mixer RCT basic Kika Labortechnik 
Magnetic Seperator QuadroMACS Miltenyi Biotec 
Microcentrifuge GalaxyMiniStar VWR International 
Microscope CKX41 Olympus 
Microtiterplate-reader Tecan infinite M1000 Tecan Group Ltd. 
 TriStar2 LB 942 Berthold Technologies 
Nanodrop Nanodrop 2000 Thermo Scientific 
PCR Thermocycler T3000 Biometra 
Photometer Eppendorf Bio Thermo Scientific 
Power Supply Power Pac 3000 Bio-Rad Laboratories, Inc. 
Protein blotting system Trans-Blot Turbo Bio-Rad Laboratories, Inc. 
Shaker Titramax 101 Heidolph 
Thermomixer Eppendorf comfort Thermo Scientific 
Tumbling table Biometra WT 12 Biometra GmbH 
Vacuum gas pump VP 86 VWR International 
Vortexing device Omnilab REAX 2000 Heidolph 
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2.1.10 Kits 
Table 8: Kits 
Name Manufacturer 
Amersham ECL Detection reagents GE Healtcare 
BCA Protein Assay Kit Thermo Scientific 
BD OptEIA™ TMB Substrate Kit for ELISA BD Biosciences 
CellTiter-Glo® Luminescent Cell Viability Assay Promega 
CyQuant®Direct Cell Proliferation Assay Kit Molecular Probes 
CytoTox-Glo™ Cytotoxicity Assay Promega 
DuoSet ELISA 15 Plate (mouse IL-1 beta/IL-1F2, IL-6, TNF-α) R&D Systems, Inc. 
HiScribe T7 ARCA mRNA kit (with polyA tailing) New England BioLabs 
jetMESSENGER
®
 Polyplus transfection 
MEGAclear transcription clean-up kit Qiagen 
ProcartaPlex™ Multiplex Immunoassay eBioscience 
QIAquick PCR purification Quiagen 
 
2.1.11 Software 
Table 9: Software 
Programm Provider 
CellQuest Pro BD Bioscience 
Fluoview FV10 ASW 1.7b Olympus Corporation 
GraphPad Prism 5.04 GraphPad Software, Inc. 
ImageJ 1.46h Wayne Rasband 
Micro Win 2000 Berthold Technologies 
Nanodrop 2000 software Thermo Scientific 
Office Professional Plus 2010 Microsoft 
Photoshop CS3 Adobe 
Tecan i-control 1.7 Systat Software, Inc 
 
2.2. Methods 
All cells were plated and incubated overnight at 37 °C with 5 % CO2-enriched and water vapour 
saturated atmosphere without antibiotics one day prior to experiments were performed. All cells 
were centrifuged at 650 x g, at 4 °C for 5 min unless otherwise specified. 
2.2.1 Molecularbiological methods 
All PCR reactions were performed in a PCR Thermocycler T3000 (Biometra) and nucleic acids 
concentrations were determined with a Nanodrop (Thermo Scientific) as not further indicated. 
Wild type and NEMOC54/347A constructs (originally aquired from Addgene) were kindly provided 
by T. Gilmore (Boston University, Massachusetts, USA). 
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2.2.1.1 Transformation and replication of DNA 
Transformation and replication of wild type NEMO, mutant NEMOC54/374A, IKK1 and IKK2 
plasmids was kindly achieved by Daniela Grumme from AG Krönke with the QIAGEN Plasmid 
Miniprep Kit in accordance with the manufacturer’s instructions. Plasmids were purified with the 
QIAquick PCR Purification Kit in accordance with the manufacturer’s instructions. 
2.2.1.2 Linearisation of Plasmids 
Linearisation of the wild type NEMO and mutant NEMOC54/347A DNA plasmids was achieved with 
the FastDigest XBaI restriction kit. 10 µg of DNA was mixed with 80 µl RNAse-free water, 10 µl 
10X FastDigest buffer and 5 µl XbaI FastDigest, vortexed and briefly centrifuged. Restriction 
was achieved by incubation at 37 °C with 500 rpm O/N. Linearised plasmids were purified with 
the QIAquick PCR Purification Kit in accordance with the manufacturer’s instructions. 
2.2.1.3 T7-Promotor PCR 
All kit components were thawed, vortexed, briefly centrifuged and kept on ice. 
Linearised NEMO constructs already contain a T7-Promotor sequence. Addition of the T7-
Promotor to IKK1 and IKK2 DNA templates was achieved by using the Q5® High-Fidelity 
Polymerase. 10 ng of linearized DNA template was mixed with 0.1 µl T7-Promotor forward 
primer and 0.1 µl T7-Promotor reverse primer. The reaction mix was filled up to 25 µl total with 
RNAse-free water, vortexed and briefly centrifuged. The program ‚”T7-Promotor PCR” (Table 5) 
was used for this PCR. Linearised T7-Promotor-plasmids were purified with the QIAquick PCR 
Purification Kit in accordance with the manufacturer’s instructions. 
Quality control was assessed by electrophoresis on a 1 % agarose gel. Gels were prepared by 
heating 1 gram agarose in TAE buffer (1X) until dissolved. 10 µl GelRed® was added. After 30 
min of polymerization, gels were assembled in a tank filled with TAE (1X). 1 µl per DNA sample 
was mixed with 2 µl Orange DNA loading dye (1X) and 7 µl of H2Obidest, vortexed, briefly 
centrifuged and immediately loaded into the gel. For DNA length determination 6 µl of 
O’GeneRuler™ was loaded into the gel. Electrophoresis was performed at 100 V constant 
current. Gels were analyzed with a ChemiDocTM (Bio-Rad Laboratories, Inc.). 
2.2.1.4 mRNA-Synthesis 
All kit components were thawed, vortexed, briefly centrifuged and kept on ice. All incubation 
steps were performed at 400 rpm and 37 °C with a Thermomixer (Thermo Scientific) as not 
further indicated. 
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T7-mRNA synthesis was achieved by using the HiScribe™ ARCA mRNA Kit (with Tailing) 
(NEB) in accordance with the manufacturer’s instructions. 1 µg of T7-Promotor DNA template 
was mixed with 10 µl of 2X ARCA/NTP Mix and 2 µl T7 RNA Polymerase Mix. In addition, 0.5 µl 
of Pseudo-UTP and 0.5 µl 5mCTP were added for immunogenic reduction. The reaction mix 
was filled up to 20 µl total with RNAse-free water, vortexed, briefly centrifuged and incubated for 
30 min to generate a T7-Promotor guided mRNA construct. 
2 µl of DNAse was added to the 20 µl reaction mix. The mix was vortexed, briefly centrifuged 
and incubated for 15 min to remove T7-DNA templates. 
22 µl of mRNA was mixed with 5 µl of 10X Poly(A) Reaction Polymerase Reaction buffer and 5 
µl Poly(A) Polymerase. The reaction mix was filled up to 50 µl total with 18 µl of RNAse-free 
water, vortexed, briefly centrifuged and incubated for 30 min to add a Poly(A)-Tail to the 
construct. This step enhances durability in the cytosol of transfected cells. 
50 µl of Poly(A)-tailed mRNA was mixed with 6 µl of 10X Antarctic phosphatase Reaction buffer 
and 3 µl Antarctic phosphatase. The reaction mix was filled up to 60 µl total with 1 µl of RNAse-
free water, vortexed, briefly centrifuged and incubated for 30 min to remove phosphate residues 
from mRNA 5‘- and 3‘-ends. Samples were heated at 80 °C for 2 min to inactivate the 
phosphatase. This step prevents religation of mRNA constructs. 
To remove unused NTPs, enzymes and buffer components, synthesized and modified mRNA 
constructs were purified with the MEGAclearTM Transcription Clean-up Kit in accordance with 
the manufacturer’s instructions. 
Quality control of mRNA synthesis and purification was assessed by electrophoresis on a 
denaturing formaldehyde agarose gel. Gels were prepared by heating 0.6 g agarose in 1X 
Running buffer until dissolved, then cooled to 65 °C. 900 µl formaldehyde (37 %) and 0.5 µl 
ethidium bromide was added. After 30 minutes of polymerisation gels were assembled in a tank 
filled with Running buffer (1X) and incubated for another 30 minutes for equlibration. 10 µl per 
RNA sample was mixed with 2.5 µl of RNA loading buffer (5X) vortexed, heated at 65 °C for 5 
minutes and after short cooling on ice immediately loaded into the gel. For RNA length 
determination 32 µl of RNA ladder was mixed with 8 µl of RNA loading buffer (5X) and also 
loaded into the gel. Electrophoresis was performed at 7 V/cm and 60 V constant current. Gels 
were analyzed with a ChemiDocTM (Bio-Rad Laboratories, Inc.). 
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2.2.2 Cultivation of bacteria 
Log-phase cultures of wt, Δhly, and Δprf Listeria monocytogenes (wt L.m., Δhly L.m., Δprf L.m.), 
Bacillus subtilis (B.sub), Escherischia coli (E.coli), were thawed and plated out on blood agar 
plates and grown overnight at 37 °C. Single colonies were picked and expanded in 5 ml BHI 
overnight at 37 °C and 220 rpm. Before experiments, overnight cultures were diluted 1:25 in 
pre-warmed BHI medium and incubated at 37 °C for two hours with 220 rpm. Bacteria were 
harvested during midlog-growth phase with an optical density of 0.3 at 600 nm (OD600). 
Bacterial suspensions were transferred into a 50 ml falcon tube and centrifuged at 3000 x g for 
5 min and 4 °C. Supernatants were removed and pellets were washed once with 10 ml ice-cold 
PBS. After centrifugation, supernatants were removed and pellets were resuspended in 1 ml of 
ice-cold PBS. Bacterial suspensions were mixed by vortexing and diluted 1:20 in PBS for OD 
measurement. Density of bacteria was determined by OD600 measurement (OD600 1 
corresponds to 5 x 108 CFU/ml) and bacterial suspensions were diluted to a stock concentration 
of 1 x 109 CFU/ml. The stock suspension was used for adjusting the innocula for the 
experiments. Serial dilutions of innocula were plated on blood agar plates to quantify adjusted 
CFUs. 
2.2.3 Isolation of peritoneal cells 
Mice were sacrificed by cervical dislocation and peritoneal cells were harvested by peritoneal 
lavage with 8 ml ice-old PBS. Peritoneal lavages of mice with the same genotype were pooled. 
After centrifugation, supernatants were removed and red blood cells were lysed in 5 ml 0.2 % 
NaCl solution for 30 s. Lysis was stopped by adding 5 ml of 1.6 % NaCl solution. 
2.2.4 Immunomagnetic enrichment peritoneal macrophages 
After peritoneal lavage and red blood cell lysis, cells were centrifuged and supernatant was 
removed. Cell pellets were resuspendend in MACS buffer (97.5 µl per 1 peritoneal exudate). 
CD11b-specific monoclonal antibodies conjugated to paramagnetic beads (CD11b MicroBeads) 
were added to the cell suspension (2.5 µl per 1 peritoneal exudate) and cells were labeled on 
ice for 15 min with 300 rpm. After labeling, cells were washed three times and sorted in 
accordance with the protocol of the manufacturer (Miltanyi, Biotec). After elution from the MS 
columns, cells were resuspendend in DMEM supplemented with 10 % heat-inactivated FCS 
(DMEM + FCS), cells were diluted and counted in Trypan Blue in a Neubauer chamber for cell 
number determination and exclusion of dead cells. 
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2.2.5 Flow cytometric analysis of peritoneal macrophages 
All incubation steps were performed for 15 min on ice and 300 rpm. Aliquots from counted cell 
suspensions were transferred in a 96-well clear V-bottom plate and 1 µl FcBlock (BD 
Pharmingen) was added in order to block unspecific Fc-binding sites. After incubation, cells 
were incubated with 0.5 µl PE-conjugated F4/80 antibodies (clone BM8), 0.5 µl APC-conjugated 
CD11b antibodies (clone M1/70) or a combination of both. Cells were washed three times by 
centrifugation and resuspension with MACS buffer. Finally, cells were fixed with FACS Fix 
solution and transferred to FACS tubes. The percentage of F4/80high/CD11bhigh peritoneal 
macrophages was determined by flow cytometry with a FACS Calibur flow cytometer (BD 
Biosciences) and CellQuest Pro software (BD Biosciences). Peritoneal macrophages were 
diluted in DMEM + FCS to desired densities, plated out and shortly centrifuged for better 
adherence. 
2.2.6 Transfection of peritoneal macrophages 
For transfection of peritoneal macrophages 200 ng of indicated mRNA constructs were 
complexed to jetMESSENGER (Polyplus-transfection) in accordance with the manufacturer’s 
instructions. After 6 h of infection, medium was exchanged and cells were subjected to further 
experiments. 
2.2.7 Quantification of ROS 
Peritoneal macrophages were plated out at a density of 5 x 105 cells/well as triplicates in DMEM 
+ FCS in sterile 96F plates. White or black closed bottom plates were used for luminescence or 
fluorescence measurements, respectively. Pre-treatments were applied by adding 10 µl of the 
given substance diluted in DMEM + FCS followed by incubation for 30 min at 37 °C. Cells were 
centrifuged and washed once with HBSS to remove non-adherent cells and added substances 
for pre-treatment. For infection or co-incubation, ice cold suspensions of wt L.m., Δhly L.m. or 
Δprf L.m., B.sub, or E.coli with a multiplicity of infection (MOI) of 1 or heat-killed L.m. (HK L.m.) 
at an MOI-equivalent of 1 were added to wells. Cells without infection received ice-cold HBSS 
without bacteria. Contact of bacteria to macrophages was achieved by synchronization at 850 x 
g for 5 min at 4 °C. Every working step after infection was performed on ice. Non-adherent 
bacteria were removed by washing for three times with ice-cold HBSS. Cells were covered with 
ice cold HBSS and test compounds were added. As a positive control for extra- and cytosolic 
ROS measurements PMA, a chemical stimulator of ROS, was added with a final concentration 
of 1 ng/ml. For ROS measurement in the mitochondrial matrix rotenone, an inhibitor of complex 
I of electron transport chain, was used as a positive control with a final concentration of 100 µM. 
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2.2.7.1 Measurement of extracellular ROS production 
For detection of extracellular ROS, a prepared ice-cold solution of cell-impermeable isoluminol 
and horseradish peroxidase (HRP) in HBSS was used with final concentrations of 50 µM and 
3.2 U/ml, respectively. The enzyme horseradish peroxidase uses the produced ROS to catalyze 
the conversion of isoluminol to the excited 3-aminophtalate. This product decays to lower 
energy state and emits light in the process, which can be detected as chemiluminescence. After 
infection and treatment with substances (2.2.7), isoluminol/HRP solution was added to the wells 
and chemiluminescence was recorded for 60 min with 60 s intervals at 37 °C in a Tristar2 
multimode plate reader LB 942 (Berthold Technologies). To calculate cell-specific 
luminescence, the luminescence of cell-free wells containing HBSS with or without used 
substances was substracted. 
2.2.7.2 Measurement of cytosolic ROS production 
For detection of cytosolic ROS, the substance 5,6-carboxy-2’,7’-dichlorodihydroflurescein 
diacetate, di(acetoxymethyl ester) (referred to as DCF in this thesis) (Invitrogen) was used. DCF 
was diluted to a final concentration of 20 µM in HBSS. Cells were incubated with DCF solution 
at 37 °C for 15 min. DCF is a hydrophilic molecule, which readily enters cells by diffusion during 
incubation. After reaching the cytosol, ester groups of the DCF molecule are cleaved by 
cytosolic esterases, leading to the loss of hydrophilicity. Lipohilic DCF is trapped in cytosol as 
dihydrofluorescein. Cleaving of the ester groups also leads to the exposure of functional groups 
that are able to react with ROS. After reaction with ROS, dihydrofluorescein is converted to its 
oxidized and fluorescent derivate fluorescein. After incubation, cells were centrifuged and 
washed for two times with ice cold HBSS. Cells were infected as described in 2.2.7. After 
infection and addition of test compounds, cells were covered with ice cold HBSS. Fluorescein 
was exitated at 495 nm and emitted fluorescence at 520 nm was recorded for 60 min with 60 s 
intervals at 37 °C in TriStar2 multimode plate reader LB 942 (Berthold Technologies). To 
calculate cell-specific fluorescence, the fluorescence of cell-free wells containing HBSS with or 
without used substances was subtracted. 
2.2.7.3 Measurement of ROS production in the mitochondrial matrix 
ROS production in the mitochondrial matrix was detected by using the fluorescence probe 
MitoSOX Red (ThermoFisher Scientific). MitoSOX Red was diluted to a final concentration of 5 
µM in HBSS. Cells were incubated with MitoSOX Red solution at 37 °C for 15 min. MitoSOX 
Red accumulates in the mitochondrial matrix and is oxidized exclusively by superoxide. After 
incubation, cells were washed for three times with ice cold HBSS. Cells were infected as 
described in 2.2.7. After infection and addition of test compounds, cells were covered with ice 
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cold HBSS. MitoSOX Red was exitated at 510 nm and emitted fluorescence at 580 nm was 
recorded for 60 min with 60 s intervals at 37 °C in a TECAN infinite M 1000 microplate reader 
(Tecan Group, Ltd.). To calculate cell-specific fluorescence, the fluorescence of cell-free wells 
containing HBSS with or without used substances was subtracted. 
2.2.8 Cytokine quantification 
2.2.8.1 Preparation of supernatants 
Peritoneal macrophages were plated at a density of 1.5 x 105 cells/well as duplicates in DMEM 
+ FCS in sterile 24-well plates. Pre-treatments were applied by adding 10 µl of the given 
substance diluted in DMEM + FCS followed by incubation for 30 min at 37 °C. Cells were 
centrifuged and washed with HBSS to remove non-adherent cells and added substances for 
pre-treatment. For infection, ice cold suspensions of L.m, B.sub or E.coli with a MOI of 1 were 
added to the wells. Cells without infection received ice-cold HBSS without bacteria. Contact of 
bacteria to macrophages was achieved by synchronization at 850 x g for 5 min at 4° C. Non-
adherend bacteria were removed by washing for three times with ice-cold HBSS. Cells were 
covered with pre-warmed HBSS with 5 % heat-inactivated NMS (HBSS + NMS) with or without 
test compounds and incubated at 37 °C. At indicated time points supernatants were transferred 
into a 96U-plate and centrifuged at 650 x g for 5 min at 4 °C to remove cell debris. Cleared 
supernatants were transferred into a 96F-plate and stored at -80 °C until cytokine determination. 
2.2.8.2 ELISA (Enzme-linked immunosorbent assay) 
Cytokines in supernatants were measured by ELISA using capture- and detection antibodies 
(R&D Systems) in accordance with the manufacturer’s instructions. Absorbance was measured 
with a TECAN infinite M 1000 (Tecan Group, Ltd.). 
2.2.9 Measurement of mitochondrial membrane potential 
Peritoneal macrophages were isolated and immunomagnetically enriched as described in 2.2.3 
and 2.2.4. TMRE (Tetramethylrhodamine, ethyl ester) was diluted to a final concentration of 50 
nM in HBSS. Cell pellets were resuspended in 1 ml TMRE solution and filled up to 5 ml final 
volume. Cells were incubated on a spinning wheel at 37 °C for 15 min. TMRE accumulates in 
the mitochondrial matrix due to its cationic properties and the negative charge of the matrix. The 
negative charge is stable as long as protons are pumped across the inner mitochondrial 
membrane. The charge separation across the membrane causes the mitochondrial membrane 
potential. Accumulated TMRE shows a red shift in its fluorescence properties and represents 
stable membrane potential. Loss of membrane potential results in release of TMRE from 
mitochondria and in a decreased fluorescence signal. After centrifugation, cells were 
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resuspended and washed three times with pre-warmed HBSS. Cell numbers were determined 
as described in 2.2.4. Cells were plated at a density of 0.5 x 106 cells/well and incubated for two 
hours to allow adhesion. Infection was performed as described in 2.2.7. Finally, cells were 
covered with HBSS + NMS with or without test compounds and incubated at 37 °C. The proton 
shuttling substance carbonyl cyanide m-chlorophenyl hydrazone (CCCP) was used as a 
negative control. At indicated time points TMRE was exitated at 549 nm. Emitted fluorescence 
at 575 nm was recorded with a TECAN infinite M 1000 microplate reader (Tecan Group, Ltd.). 
To calculate cell-specific fluorescence, the fluorescence of cell-free wells containing HBSS with 
or without used substances was substracted. 
2.2.10 Measurement of cellular ATP levels 
Cells were plated and infected as described in 2.2.7. Cells were covered with pre-warmed 
HBSS + NMS with or without test compounds and cells were incubated at 37 °C. CCCP was 
used as a negative control. ATP content was determined by using the CellTiter-Glo® 
Luminescent Cell Viability Assay in accordance to the manufacturer’s instructions (Promega). At 
indicated time points, chemiluminescence was recorded in a Tristar2 multi mode plate reader LB 
942 (Berthold Technologies). To calculate cell-specific luminescence, the luminescence of cell-
free wells containing HBSS with or without used substances was substracted. 
2.2.11 Cell viability/cytotoxicity assays 
Cells were plated, infected and treated as described in 2.2.7. Cells were covered with pre-
warmed HBSS + NMS with or without test compounds and cells were incubated at 37 °C. 
2.2.11.1 Determination of cell death 
The CytoTox-Glo™ Cytotoxicity Assay was used to determine death due to loss of membrane 
integrity. At indicated time points, cells were treated in accordance with the manufacturer’s 
instructions (Promega) and fluorescence was recorded with a TECAN infinite M 1000 microplate 
reader (Tecan Group, Ltd.). 
2.2.11.2 Determination of cell viability 
The CyQUANT® Direct Cell Proliferation Assay was used to determine cell viability. At indicated 
time points, cells were treated in accordance with the manufacturer’s instructions (Promega) 
and fluorescence was recorded with a TECAN infinite M 1000 microplate reader (Tecan Group, 
Ltd.). 
2.2.12 Cell fixation for microscopy 
Peritoneal macrophages were plated at a density of 3 x 105 cells/well in DMEM + FCS on sterile 
13 mm Ø cover cells in sterile 24-well plates. Cells were infected, treated and incubated as 
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described in 2.2.8. At indicated time points medium was removed, cells were washed once with 
ice cold PBS and fixed with 3 % PFA in PBS for 20 min at RT. PFA was removed, cells were 
covered with PBS and stored at 4 °C until immunofluorescence staining (2.2.13). 
2.2.13 Immunofluorescence staining 
All antibodies used for extracellular staining were diluted in PBS containing 3 % BSA and all 
antibodies used for intracellular staining were diluted in PBS containing 3 % BSA and 0.1 % 
saponin as not described otherwise. All incubation steps were performed for 30 min at RT as 
not otherwise specified. 
PBS was removed and cells were covered with 1 ml 3 % BSA in PBS for 15 min to block 
unspecific binding sites. Extracellular L.m. were stained with primary rabbit anti-L.m. antibody. 
Cells were washed three times with 1 ml PBS and secondary anti-rabbit-antibody, conjugated to 
AlexaFlour 405 fluorescence dye, was added to cells. Cells were permeabilized before 
intracellular staining by incubation with 0.1 % saponin in PBS for 15 min. Unspecific binding 
sites were blocked using 3 % BSA and 0.1 % saponin in PBS for 15 min. Intracellular L.m. were 
stained with primary rabbit anti-L. monocytogenes antibody diluted in 3 % BSA and 0.1 % 
saponin in PBS. Cells were washed three times with 1 ml PBS. Intracellular L.m. were stained 
with secondary anti-rabbit antibody, conjugated to AlexaFluor 568 fluorescence dye. Cells were 
washed twice with PBS and once with H2Obidest . Additional stainings were performed dependent 
to the following experiments (see 2.2.13.1, 2.2.13.2 and 2.2.13.3). Finally, cells were mounted 
on microscope slides in ProLong Gold antifade reagent. Sections of preparations were analyzed 
with an IX81 confocal fluorescence microscope (Olympus). 
2.2.13.1 Staining for translocation analysis of NF-κB 
Intracellular NF-κB p65 was stained with primary mouse anti-NF-κB p65 antibodies. After 
washing, NF-κB p65 was stained with secondary anti-mouse antibodies, conjugated to 
AlexaFlour 488 fluorescence dye. Nuclei were stained with DAPI, diluted with secondary 
antibodies. 
2.2.13.2 Staining of mitochondria 
For analysis of the mitochondrial network, mitochondria were stained with the mitochondrial 
membrane potential-sensitive dye MitoTracker Red CMXRos (Thermo Scientific) at 100 nM for 
15 min at 37 °C. After staining peritoneal macrophages were infected, treated and incubated as 
described in 2.2.8. CCCP was used as positive control (50 µM). 
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2.2.13.3 Staining of FLAG-tagged NEMO and IKKβ constructs 
Transfection (2.2.6), infection (2.2.8) and fixation (2.2.12) were performed as described before. 
Peritoneal macrophages were permeabilized with 0.25 % Triton X-100. After blocking with 10 % 
BSA in PBS, FLAG-tagged proteins were stained using a monoclonal antibody against FLAG at 
37 °C for 2 h. After washing, NEMO constructs or IKKβ constructs were stained with secondary 
anti-mouse antibodies, conjugated to AlexaFlour 488 fluorescence dye. Nuclei were stained 
with DAPI, diluted with secondary antibodies. Samples were mounted on glass microscopic 
slides and stored at 4 °C until analysis. 
2.2.14 Western blotting for protein analysis 
All incubation steps were performed at RT on an orbital shaker with 300 rpm as not further 
indicated. 
2.2.14.1 Preparation of cell lysates (Standard SDS-PAGE, reducing) 
Peritoneal macrophages were plated at a density of 1 x 106 cells/well in DMEM + FCS in sterile 
12-well plates. Cells were transfected (2.2.6), infected (2.2.8), treated and incubated (2.2.8) as 
described before. At indicated time points medium was removed and cells were washed once 
with ice cold PBS. Ice cold RIPA lysis buffer was added and cells were lysed for 10 min at RT 
with 1000 rpm. Cell lysates were transferred into 1.5 ml tubes and proteases were inactivated 
by heating for 10 min at 95 °C. Finally, lysates were incubated on ice for 1 min, briefly 
centrifuged at 10,000 x g and stored at -80 °C until determination of protein concentration 
(2.2.14.3). 
2.2.14.2 Preparation of cell lysates (SDS-PAGE, non-reducing) 
Peritoneal macrophages were plated at a density of 1 x 106 cells/well in DMEM + FCS in sterile 
12-well plates. Cells were transfected (2.2.6), infected (2.2.8), treated and incubated (2.2.8) as 
described before. At indicated time points medium was removed and cells were washed once 
with ice cold PBS. AT-Lysis buffer was added and cells were lysed for 1 h at RT with 1000 rpm. 
Cell lysates were transferred into 1.5 ml tubes and proteases were inactivated by heating for 10 
min at 95 °C. Finally, lysates were incubated on ice for 1 min, briefly centrifuged at 10,000 x g 
and directly subjected to non-reducing SDS-PAGE (2.2.14.5). 
2.2.14.3 BCA Protein Assay 
Protein concentration was determined by using the BCA Protein Assay Kit in accordance with 
the manufacturer’s instructions (Pierce, Thermo Scientific). Final protein concentrations were 
equally adjusted for each experiment in 5X Laemmli buffer (with or without β-mercaptoethanol) 
and H2Obidest.. 
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2.2.14.4 Standard SDS-PAGE (reducing) 
SDS-PAGE was performed in accordance with the protocol of the manufacturer (Bio-Rad 
Laboratories, Inc.) by using a Criterion Gel cassette containing a 12 % Tris/HCl gel mounted in 
a Criterion Cell filled with 1X TGS running buffer. Lysates were heated for protein denaturation 
for 10 min at 95 °C, incubated on ice for 1 min and briefly centrifuged (10,000 x g, 1 min, RT) 
before gel loading. SDS-PAGE was performed at a constant voltage of 70 V. Gels were 
incubated in 1X Roti®-Blot K cathode buffer until protein transfer. 
2.2.14.5 SDS-PAGE (non-reducing) 
SDS-PAGE was performed in accordance with the protocol of the manufacturer (Bio-Rad 
Laboratories, Inc.) by using a Criterion Gel cassette containing a 10 % Tris/HCl gel mounted in 
a Criterion Cell filled with 1X TGS running buffer. Lysates were heated for protein denaturation 
for 10 min at 95 °C without β-mercaptoethanol, incubated on ice for 1 min and briefly 
centrifuged (10,000 x g, 1 min, RT) before gel loading. SDS-PAGE was performed at a constant 
voltage of 70 V. Gels were incubated in 1X Roti®-Blot K cathode buffer until protein transfer. 
2.2.14.6 Western Blot 
Protein transfer from the gel onto a nitrocellulose membrane was achieved by using a Trans-
Blot® Turbo™ Transfer system. Blotting was performed with the StandardSD protocol (constant 
25 V, 1 A, 30 min) in accordance to the manufactuer’s instructions. 
2.2.14.7 Antibody staining 
After protein transfer, membranes were incubated in blocking buffer for 1 h to block unspecific 
binding sites. Blocking buffer was removed and membranes were incubated with primary 
antibody diluted in blocking buffer O/N at 4 °C. Next day unbound primary antibodies were 
removed by triple washing in TBS-T for 5 min. Afterwards, membranes were incubated with 
HRP-conjugated secondary antibodies for 1 h. Unbound secondary antibodies were removed by 
double washing in TBS-T. Membranes were washed once in TBS to remove remaining 
detergent and stored in TBS at 2-8 °C until visualization. 
2.2.14.8 Protein visualisation 
Immune complexes were visualized by incubating membranes in Amserham ELC detection 
reagents (GE Healthcare) or LumiGlo Reserve Chemiluminescent substrate (KPL, Inc.) for 1 
min and detected by exposure to Amserham Hyperfilms (GE Healthcare). Films were developed 
in a Curix Developer (AGFA) or with a ChemiDocTM (Bio-Rad Laboratories, Inc.). PageRuler 
Prestained Protein Ladder (Thermo Scientific) or HiMark™ Pre-stained Protein Standard was 
used for protein size determination and specific bands were quantified by densiometry using the 
ImageJ 1.46 software (Wayne Rasband, NHI). 
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2.2.15 Electrophoretic mobility shift assay (EMSA) 
Peritoneal macrophages were plated out at a density of 1 x 106 cells/well in DMEM + FCS in 
sterile 12-well plates. Cells were transfected, infected, treated and incubated as described in 
2.2.6 and 2.2.8. At indicated time points medium was removed and cells were washed once 
with ice cold PBS. After washing 200 µl cold EMSA buffer A was added and cells were 
incubated for 4 min on ice. Lysis of cells was achieved by adding 12.5 µl of 10 % Triton and 
incubation for another 3 min on ice. Lysates were transferred to 1.5 ml tubes and centrifuged at 
17,900 g for 5 min. The cytosolic fractions in supernatants were removed by careful. The pellet 
containing the nuclear fraction was resuspendend in 30 µl of EMSA buffer C and incubated at 4 
°C with 1400 rpm for 20 min. Nuclear lysates were centrifuged at 17,900 g for 5 min. The 
nuclear lysates in supernatants were carefully transferred to 1.5 ml tubes and stored at -80 °C. 
The pellet containing cell debris and chromatin was discarded. Nuclear extracts were 
normalized for protein content with BCA (2.2.14.3). The NF-κB-specific oligonucleotides 
containing two tandemly arranged NF-κB binding sites of the HIV-1 long terminal repeat 
enhancer (5-ATCAGGGACTTTCCGCTGGGGACTTTCCG-3) were end-labeled with [γ-
P32]ATP using a polynucleotide kinase. EMSA was performed by incubating 5 µg of nuclear 
extract with 500 ng poly(dI:dC) in EMSA binding buffer in a final volume of 20 µl for 20 min at 
RT. Then, end-labeled double-stranded oligonucleotide probe (2x104 cpm) was added, and the 
reaction mixture was incubated for 7 min. The samples were fractionated by electrophoresis 
through a 6 % polyacrylamide gel in low-ionic-strength buffer (0.25 X TBE). 
2.2.16 Statistical methods 
The statistical analysis of data was performed using Student’s t-test. P-values smaller than 0.05 
were considered as statistically significant (n.s., not significant; * p < 0.05, ** p < 0.01 and *** p 
< 0.001). Data were shown as mean ± standard error of the mean (SEM). 
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3. Results 
3.1. ROS production by infected macrophages 
The sources, locations, amount, subspecies and different roles of ROS vary greatly in 
dependency of stimuli and the cell type, tissue or organ investigated. Therefore, I first analyzed 
if and how peritoneal macrophages, as mature tissue macrophages, respond to bacterial 
infection. 
3.1.1. Macrophages produce extracellular and cytosolic ROS upon bacterial 
infection 
ROS can be produced and act in different subcellular locations such as the lumen of 
phagosomes and the extracellular milieu (extracellular ROS) or the cytoplasm (intracellular 
ROS). Extracellular ROS can be measured with cell-impermeable dyes such as isoluminol 
(Lundqvist et al., 1996) (Fig. 12A), whereas intracellular ROS levels can be assessed by cell-
permeable dyes such as the DCF derivative 5,6-carboxy-2',7'-dichlorodihydrofluorescein 
diacetate, di(acetoxymethyl ester) (referred to as DCF throughout this thesis) that exclusively 
measures ROS that reach the cytosol (Hempel et al., 1999) (Fig. 12B). 
Macrophages produced substantial quantities of both extracellular (Fig. 12C) and cytosolic ROS 
(Fig. 12D) after L.m. infection. In addition, co-incubation of macrophages with apathogenic 
bacteria such as Bacillus subtilis (B.sub) (Fig. 12E-F) or Escherischia coli (E.coli) (Fig. 12G-H) 
also induced extracellular and cytosolic ROS production but to a lower degree as compared to 
L.m. infection, indicating that ROS production is a general response of macrophages after 
bacterial recognition. 
3. Results 
37 
 
 
Figure 12: Macrophages produce extracellular and cytosolic ROS upon bacterial infection 
Macrophages were infected with L.m. or co-incubated with  B.sub or E.coli at a MOI of 1 or 10. The kinetics of ROS 
production and the area under the curve (AUC), as a measure for the total amount of ROS produced, are shown. 
(A) Isoluminol detects extracellular ROS. 
(B) DCF detects cytosolic ROS. 
(C, E, G) Extracellular ROS production was quantified by measuring isoluminol chemiluminescence (n=7). 
(D, F, H) Cytosolic ROS production was quantified by measuring DCF fluorescence (n=9). 
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3.1.2. ROS are required for pro-inflammatory cytokine secretion during 
bacterial infection 
While the direct anti-bacterial roles of ROS in macrophages are well characterized (Gluschko 
and Herb et al., 2018; Herb et al., 2018; Garaude et al., 2016; Schramm et al., 2014; Fang, 
2011; West et al., 2011b), so far only few studies exist that investigated possible roles of ROS 
in pro-inflammatory signaling (Kelly et al., 2015; Bulua et al., 2011a). These studies came to 
different and partly contrasting conclusions, probably because of the use of different cell types 
such as bone marrow-derived macrophages (BMDM) (Kelly et al., 2015) and mouse embryonic 
fibroblasts (MEFS) (Bulua et al., 2011a). Moreover, none of these studies investigated pro-
inflammatory signaling in response to bacterial infection. I used the pathogen L.m. as a well-
established infection model for macrophages that activates multiple signaling pathways (Ley et 
al., 2016; Mitchell et al., 2016). Therefore L.m. infection is well-suited to investigate the roles of 
ROS in the pro-inflammatory response of macrophages to a complex pathogenic stimulus. 
Both extracellular and intracellular ROS have been reported to contribute to pro-inflammatory 
signaling in macrophages (Kelly et al., 2015; Deffert et al., 2012; Bulua et al., 2011a). To 
investigate if infection-induced ROS play a role in pro-inflammatory signaling, macrophages 
were treated with the global ROS scavenger N-acetyl cysteine (NAC) (Fig. 13A+B), which 
resulted in strong reduction of both extracellular (Fig. 13C) and cytosolic (Fig. 13D) ROS 
production. Macrophages responded to bacterial infection by secretion of pro-inflammatory 
cytokines such as IL-1β, IL-6 and TNF. Notably, scavenging of ROS with NAC strongly reduced 
secretion of these cytokines in response to L.m. (Fig. 13E) and B.sub (Fig. 13F), whereas 
cytokine secretion in response to E.coli was also significantly reduced yet to a minor extend 
(Fig. 13G). These data indicate that ROS play an important role in the pro-inflammatory 
response to bacterial infection in macrophages. 
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Figure 13: ROS are required for pro-inflammatory cytokine secretion during bacterial infection 
(A) Viability of macrophages after infection at a MOI of 1 for 5 hours in the presence or absence of 50 mM NAC 
(n=4). 
(B) Pyroptotic cell death of macrophages after infection at a MOI of 1 for 5 hours in the presence or absence of 50 
mM NAC. Macrophages were treated with 10 µg/ml Digitonin as a positive control (n=4). 
(C-D) Macrophages were infected with L.m. at a MOI of 1. The kinetics of ROS production and the area under the 
curve (AUC), as a measure for the total amount of ROS produced, are shown. 
(C) Extracellular ROS production was quantified by measuring isoluminol chemiluminescence (n=3) (Legend 
continued on next page). 
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Figure 13 (continued): ROS are required for pro-inflammatory cytokine secretion during bacterial infection 
(D) Cytosolic ROS production was quantified by measuring DCF fluorescence (n=3). 
(E-G) Macrophages were infected with L.m. or co-incubated with B.sub or E.coli at a MOI of 1 for 5 hours in the 
presence or absence of 50 mM NAC. Secretion of IL-1β, IL-6 and TNF was quantified by ELISA (n=5). 
 
3.1.3. Nox2 is the exclusive source of extracellular ROS 
As NAC is cell-permeable and therefore scavenges both extracellular and intracellular ROS, I 
next investigated the subcellular sources of the ROS required for secretion of pro-inflammatory 
cytokines by infected macrophages. The major ROS source in phagocytes, including 
macrophages, is the NADPH oxidase 2 (Nox2) (Gluschko and Herb et al., 2018; Sheppard et 
al., 2005; Pollock et al., 1995). Macrophages deficient for Nox2 did not produce any detectable 
amounts of extracellular ROS after infection with L.m (Fig. 14A). Even infection with an 
increased number of L.m. per macrophage did not induce ROS production in Nox2-deficent 
macrophages (Fig. 14A) clearly identifying Nox2 as the exclusive extracellular ROS source in 
L.m.-infected macrophages. 
By contrast, the increase in cytosolic ROS levels induced by L.m. infection was not 
compromised in Nox2-deficient macrophages (Fig. 14B) showing that Nox2-derived ROS, in 
contrast to extracellular ROS production, do not contribute to cytosolic ROS levels. 
3.1.4. Nox/Duox enzymes do not contribute to cytosolic ROS production 
In addition to Nox2, the family of NADPH oxidases comprises five other isoforms that could be 
responsible for the increase of cytosolic ROS levels: Nox1-5 and Duox1-2 (Lambeth et al., 
2014; Bedard et al., 2007). As Nox3 is only expressed in the inner ear (Banfi et al., 2004) and 
Nox5 is absent in mice (Banfi et al., 2001; Cheng et al., 2001), neither was addressed in this 
thesis. L.m.-infected Nox1-, Nox4-, Duox1- and Duox2-deficient macrophages produced 
unaltered amounts of cytosolic ROS in comparison to corresponding wild type (WT) cells (Fig. 
14C-F). Moreover, simultaneous deficiency for Nox1-4 in macrophages deficient for p22phox, the 
common catalytic subunit of Nox1-4, did not compromise production of cytosolic ROS (Fig. 
14G). 
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Figure 14: Nox2 is the exclusive source of extracellular ROS, whereas Nox/Duox enzymes do not 
contribute to cytosolic ROS production 
Macrophages were infected with L.m. at MOI 1 or 10. The kinetics of ROS production and the area under the curve 
(AUC), as a measure for the total amount of ROS produced, are shown. 
(A) Extracellular ROS production by WT or Nox2-KO macrophages was quantified by measuring isoluminol 
chemiluminescence (n=5). 
(B-G) Cytosolic ROS production by WT or Nox2-KO, Nox1-KO, Nox4-KO, Duox1-KO, Duox2-KO and p22
phox
-KO 
macrophages was quantified by measuring DCF fluorescence (n=5, 4, 3, 3, 4 and 4, respectively). 
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3.1.5. Nox/Duox enzymes are dispensable for pro-inflammatory cytokine 
secretion 
Since a regulatory role for Nox2-dervied ROS during pro-inflammatory signaling was described 
before (Deffert et al., 2012), I next investigated a possible role for Nox2-derived extracellular 
ROS in cytokine secretion by infected macrophages. Cytokine secretion by L.m.-infected Nox2-
deficient macrophages was normal for IL-6 and TNF and even increased for IL-1β (Fig. 15A), 
indicating that extracellular Nox2-derived ROS are dispensable for secretion of pro-
inflammatory cytokines by infected macrophages. In addition to the previously described 
unaltered cytosolic ROS production (Fig. 14C-G), macrophages deficient for Nox1, Nox4, 
Duox1 and Duox2 showed also no alterations in pro-inflammatory cytokine secretion after L.m. 
infection (Fig. 15B-E). Macrophages deficient for the p22phox-subunit showed enhanced IL-1β 
secretion (Fig. 15F), phenocopying the pro-inflammatory cytokine profile of Nox2-deficient 
macrophages. Thus, Nox/Duox enzymes are dispensable for pro-inflammatory cytokine 
secretion in infected macrophages. 
3.1.6. Cytosolic ROS production is crucial for pro-inflammatory cytokine 
secretion 
Since cytosolic ROS production was unaltered in Nox2-deficient macrophages, I additionally 
treated these cells with NAC to eliminate Nox2-independent cytosolic ROS production. 
Importantly, additional ROS scavenging with NAC in Nox2-deficient macrophages reduced 
secretion of cytokines to a similar degree as in WT macrophages (Fig. 15A) suggesting a role 
for cytosolic ROS in cytokine secretion. These results clearly indicate that none of the Nox/Duox 
family members is involved in cytosolic ROS production or pro-inflammatory cytokine secretion 
by infected macrophages and show that cytosolic ROS, but not extracellular, Nox2-dervived 
ROS, play a crucial role in pro-inflammatory cytokine secretion. 
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Figure 15: Cytosolic ROS production independent of Nox/Duox enzymes is necessary for pro-inflammatory 
cytokine secretion (Legend continued on next page). 
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Figure 15 (continued): Cytosolic ROS production independent of Nox/Duox enzymes is necessary for pro-
inflammatory cytokine secretion 
Macrophages were infected with L.m. at a MOI of 1 for 5 hours in the presence or absence of 50 mM NAC. 
(A-F) Secretion of IL-1β, IL-6 and TNF by WT or Nox2-KO, Nox1-KO, Nox4-KO, Duox1-KO, Duox2-KO and 
p22
phox
-KO macrophages was quantified by ELISA (n=9, 6, 6, 6, 3 and 5, respectively). 
 
3.1.7. Cytosolic ROS do not originate from the mitochondrial matrix 
Another source of cytosolic ROS are mitochondria, which generate ROS by the respiratory 
electron transport chain (ETC) as byproduct of energy production (Cortassa et al., 2014). The 
mitochondrial ETC produces ROS either into the mitochondrial matrix (via complexes I, II and 
III) or into the IMS (via complex III, exclusively) (Dan Dunn et al., 2015; West et al., 2011b). 
From the IMS, ROS can reach the cytosol by diffusion. Several studies showed that bacterial 
infection can trigger ROS production into the mitochondrial matrix (Kelly et al., 2015; Bulua et 
al., 2011a; West et al., 2011b; Zhou et al., 2011; Chandel et al., 2000). Therefore, I first tested if 
L.m. infection induces ROS production into the mitochondrial matrix and if these ROS contribute 
to pro-inflammatory signaling. ROS production into the mitochondrial matrix can be quantified 
with MitoSOX Red, which is specifically targeted to the mitochondrial matrix (Mukhopadhyay et 
al., 2007; Robinson et al., 2006) (Fig. 16A). Rotenone-mediated blockade of electron transfer 
from complex I to complex III of the ETC is commonly used as a positive control for MitoSOX 
measurements because of reverse electron flow and subsequent ROS production into the 
matrix (Sazanov, 2014; Orr et al., 2013). Accordingly, rotenone treatment (Fig. 16B-C) 
increased ROS production into the mitochondrial matrix (Fig. 16D) showing that ROS 
production can be induced and quantified with this approach in macrophages. Notably, while 
L.m. infection of macrophages significantly increased cytosolic ROS levels (Fig. 12D) it did not 
increase ROS production into the mitochondrial matrix (Fig. 16D). Furthermore, scavenging of 
ROS specifically in the mitochondrial matrix with a mitochondrial matrix-targeted version of the 
.O2
- scavenger TEMPO (MitoTEMPO) (Fig. 16E) or by expression of the H2O2-decomposing 
enzyme catalase in the mitochondrial matrix (mCAT-knockin macrophages) (Schriner et al., 
2005) did neither reduce cytosolic ROS levels (Fig. 16F+H) nor cytokine secretion (Fig. 16G+I). 
These data show that ROS production into the mitochondrial matrix is not induced upon L.m. 
infection and does not contribute to cytosolic ROS levels or pro-inflammatory cytokine secretion. 
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Figure 16: Cytosolic ROS do not originate from the mitochondrial matrix (Figure continued on next page) 
(A) MitoSOX Red measures ROS inside of the mitochondrial matrix. 
(B, C, G, I) Macrophages were infected with L.m. at a MOI of 1 for 5 hours. 
(D, E, F, H) Macrophages were infected with L.m. at a MOI of 1. The kinetics of ROS production and the area 
under the curve (AUC), as a measure for the total amount of ROS produced, are shown. 
(B) Viability of macrophages after infection in the presence or absence of 100 µM rotenone (n=4). 
(C) Pyroptotic cell death of macrophages after infection in the presence or absence of 100 µM rotenone (n=4). 
Macrophages were treated with 10 µg/ml Digitonin as a positive control (n=4) (legend continued on next page). 
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Figure 16 (continued): Cytosolic ROS do not originate from the mitochondrial matrix 
(D) ROS production into the mitochondrial matrix was quantified by measuring MitoSOX Red fluorescence in the 
presence or absence of 100 µM rotenone as positive control (n=7). 
(E) ROS production into the mitochondrial matrix was quantified by measuring MitoSOX Red fluorescence after 30 
minutes pre-incubation with 500 µM MitoTEMPO. Treatment with 100 µM rotenone was used as positive control 
(n=7). 
(F) Cytosolic ROS production was quantified by measuring DCF fluorescence after 30 minutes pre-incubation with 
500 µM MitoTEMPO (n=4). 
(G) Secretion of IL-1β, IL-6 and TNF after pre-incubation with 500 µM MitoTEMPO was quantified by ELISA (n=6). 
(H) Cytosolic ROS production was quantified by measuring DCF fluorescence in WT and mitochondrial catalase-
knockin (mCAT-KI) macrophages (n=2). 
(I) Secretion of IL-1β, IL-6 and TNF by WT or mitochondrial catalase-knockin (mCAT-KI) macrophages was 
quantified by ELISA (n= 8). 
 
3.1.8. Cytosolic ROS are produced by complex III of the mitochondrial ETC 
Surprisingly, in contrast to its induction of ROS production into the mitochondrial matrix, 
rotenone-mediated blockade of electron transfer from complex I to complex III of the ETC 
almost completely abrogated cytosolic ROS production (Fig. 17A) as well as pro-inflammatory 
cytokine secretion in L.m.-infected macrophages (Fig. 17B). Garaude and colleagues have 
reported ROS production by complex II after E.coli infection (Garaude et al., 2016). Inhibition of 
complex II with malonate did not alter cytosolic ROS production (Fig. 17C) or cytokine secretion 
(Fig. 17D) induced by L.m. infection in macrophages. By contrast, blockade of electron transfer 
from complex III to complex IV with antimycin A (Bleier et al., 2013; Park et al., 2007) strongly 
increased cytosolic ROS levels in uninfected and infected macrophages (Fig. 17E). Together, 
these data indicate that the infection-induced cytosolic ROS, which are crucial for pro-
Figure 16 (continued) 
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inflammatory cytokine secretion by macrophages, are produced by mitochondria, but do not 
originate from the mitochondrial matrix. Instead, they are directly produced into the IMS by 
complex III from where they diffuse into the cytosol. 
 
Figure 17: Cytosolic ROS are produced by complex III of the mitochondrial ETC (Legend on next page) 
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(A, C, E) Macrophages were infected with L.m. at a MOI of 1. The kinetics of ROS production and the area under 
the curve (AUC), as a measure for the total amount of ROS produced, are shown. 
(B, D) Macrophages were infected with L.m. at a MOI of 1 for 5 hours. 
(A) Cytosolic ROS production was quantified by measuring DCF fluorescence in the presence or absence of 100 
µM rotenone (n=9). 
(B) Secretion of IL-1β, IL-6 and TNF in the presence or absence of 100 µM rotenone was quantified by ELISA 
(n=9). 
(C) Cytosolic ROS production was quantified by measuring DCF fluorescence in the presence or absence of 100 
µM malonate (n=8). 
(D) Secretion of IL-1β, IL-6 and TNF in the presence or absence of 100 µM malonate was quantified by ELISA 
(n=5). 
(E) Cytosolic ROS production was quantified by measuring DCF fluorescence in the presence or absence of 30 µM 
antimycin A (n=8). 
 
3.1.9. Cytosolic H2O2 regulates pro-inflammatory signaling 
ROS produced into the mitochondrial IMS can access the cytosol either in the form of .O2
- or 
H2O2, and both molecules can function as signaling molecules (Short et al., 2016; Chen et al., 
2009). In contrast to .O2
-, which requires voltage-dependent anion channels (VDAC) to cross the 
mitochondrial outer membrane (MOM) (Shoshan-Barmatz et al., 2010; Imai et al., 2008), H2O2 
can leave the IMS by diffusion over the MOM. To address the question which of these two ROS 
subspecies is necessary for pro-inflammatory signaling, I used specific ROS-scavenging 
chemicals. Scavenging of cytosolic .O2
- in L.m.-infected macrophages with TEMPOL did neither 
alter cytosolic ROS levels (Fig. 18A) nor markedly reduced cytokine secretion (Fig. 18B). By 
contrast, specific scavenging of cytosolic H2O2 with ebselen, a glutathione reductase-mimetic 
(Nakamura et al., 2002), reduced both cytosolic ROS levels (Fig. 18C) and cytokine secretion 
(Fig. 18E) indicating that infection-induced mitochondrial ROS reach the cytosol from the IMS 
as H2O2. In support of this notion, inhibition of SOD1 with the SOD1-specific inhibitor LCS-1 
almost completely abrogated cytokine secretion by L.m.-infected macrophages (Fig. 18F). Since 
SOD1 converts .O2
- into H2O2 both in the cytosol and in the IMS, these data further indicate that 
H2O2 is the cytosolic ROS subspecies that regulates pro-inflammatory cytokine secretion. 
Collectively, the data presented in this section show that bacterial infection of macrophages 
induces both, production of Nox2-derived extracellular ROS and mitochondria-derived cytosolic 
ROS (mtROS). Specifically, infection triggers .O2
- production into the IMS by complex III of the 
ETC. Here, O2
- is converted by SOD1 into H2O2 that diffuses into the cytosol. Moreover, while 
Nox2-derived extracellular ROS are completely dispensable for pro-inflammatory cytokine 
secretion, mtROS are crucial for secretion of pro-inflammatory cytokines. 
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Figure 18: Cytosolic H2O2 regulates pro-inflammatory signaling 
(A, C) Macrophages were infected with L.m. at a MOI of 1. The kinetics of ROS production and the area under the 
curve (AUC), as a measure for the total amount of ROS produced, are shown. 
(B, D, E, F, G) Macrophages were infected with L.m. at a MOI of 1 for 5 hours. 
(A) Cytosolic ROS production was quantified by measuring DCF fluorescence in the presence or absence of 500 
µM TEMPOL (n=2) (continued on next page). 
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Figure 18 (continued): Cytosolic H2O2 regulates pro-inflammatory signaling 
(B) Secretion of IL-1β, IL-6 and TNF in the presence or absence of 500 µM TEMPOL was quantified by ELISA 
(n=4). 
(C) Cytosolic ROS production was quantified by measuring DCF fluorescence after 60 minutes pre-incubation with 
20 µM ebselen (n=3). 
(D) Viability of macrophages after infection after 60 minutes pre-incubation with 20 µM ebselen (n=4). 
(E) Secretion of IL-1β, IL-6 and TNF after 60 minutes pre-incubation with 20 µM ebselen was quantified by ELISA 
(n=6). 
(F) Secretion of IL-1β, IL-6 and TNF in the presence or absence of 7.5 µM LCS-1 was quantified by ELISA (n=10). 
(G) Viability of macrophages after infection in the presence or absence of 7.5 µM LCS-1 (n=4). 
 
3.2. Induction mtROS production in infected macrophages 
3.2.1. mtROS production is not caused by mitochondrial perturbation 
Perturbation of mitochondria can lead to uncontrolled production of large quantities of ROS 
(Zhang et al., 2016; Motori et al., 2013; Detmer et al., 2007). The pore-forming toxin LLO of L.m. 
has been shown to damage mitochondria, which results in fragmentation of the mitochondrial 
network, and thereby impair mitochondrial function in HeLa cells (Stavru et al., 2011). L.m. 
deficient for LLO (Δhly) or for the transcriptional master regulator of L.m. virulence factors, prfA 
(ΔprfA), induced mtROS production to a similar level as wt L.m. (Fig. 17A) excluding a role for 
L.m. virulence factors in induction of mtROS in macrophages. Furthermore, while carbonyl 
cyanide m-chlorophenyl hydrazine (CCCP), a protonophore that uncouples the mitochondrial 
membrane potential (Fig. 17C), induced mitochondrial fragmentation (Fig. 17B), infection with 
L.m. did neither led to collapse of the membrane potential (Fig. 17C) nor to fragmentation of the 
mitochondrial network (Fig. 17B). Thus, mtROS production induced by L.m. infection in 
macrophages is not caused by LLO-mediated perturbation of the mitochondrial network. 
The ETC produces energy, conserved as ATP, during oxidative phosphorylation (OXPHOS). 
mtROS are generated in every respiring cell as a byproduct of OXPHOS because of electron 
leakage (Lambeth et al., 2014; Nohl et al., 2003). To test if mtROS production after L.m. 
infection of macrophages is a side effect of increased ATP generation, I investigated cellular 
ATP levels. L.m.-infected macrophages showed a rapid drop of ATP levels (Fig. 17D), 
suggesting that response to L.m.-infection is an energy consuming process. Since treatment 
with rotenone resulted in a strong reduction of both mtROS production (Fig. 15A) and pro-
inflammatory cytokine secretion (Fig. 15B) in L.m.-infected macrophages, I wanted to analyze if 
these effects are not caused by energy deprivation because of complex I inhibition. While 
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treatment with CCCP led to a strong reduction of ATP levels in uninfected as well as infected 
macrophages (Fig. 17D), treatment with rotenone did not further reduce ATP levels (Fig. 17E) 
or reduced membrane potential (Fig. 17F) in infected macrophages. These data suggest that 
the rotenone-induced effects in L.m.-infected macrophages described in section 3.1. are not 
side effects caused by energy deprivation. 
 
Figure 19: Infection-induced mtROS production is not caused by mitochondrial perturbation 
(A) Macrophages were infected with wt L.m., Δhly L.m. or ΔprfA L.m. at a MOI of 1. The kinetics of ROS production 
and the area under the curve (AUC), as a measure for the total amount of ROS produced, are shown. Cytosolic 
ROS production was quantified by measuring DCF (n=2). 
(B) Representative micrographs of Mitotracker Red-stained mitochondria in macrophages at 1 hour after infection 
or with 50 µM CCCP as positive control are shown (n=2). Scale bar represents 4 µm. 
(C) Mitochondrial membrane potential was quantified by measuring TMRE fluorescence after infection with L.m. or 
HK L.m. at a MOI of 1. Treatment with 50 µM CCCP was used as positive control. (n=5). 
(D-E) Cellular ATP levels were quantified by measuring Luciferase luminescence after infection with L.m. at a MOI 
of 1 in the presence or absence of 100 µM rotenone and with 50 µM CCCP as positive control (n=6). 
(F) Mitochondrial membrane potential was quantified by measuring TMRE fluorescence after infection with L.m. at 
a MOI of 1 in the presence or absence of 100 µM rotenone (n=6). 
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3.2.2. TRL2/MyD88/TRAF6 signaling induces mtROS production 
Since mtROS production was not a consequence of mitochondrial damage, I next investigated 
the pathway that triggers mtROS production in L.m.-infected macrophages. Salmonella 
typhimurium has been reported to induce mtROS production via the TLR4/MyD88/TRAF6 
signaling pathway (West et al., 2011a). To investigate if L.m., as a gram-positive pathogen, 
induces mtROS production in an analogous manner via TLR2 signaling, I first analyzed TLR2-
deficient macrophages. TLR2-deficent macrophages showed strongly reduced mtROS 
production (Fig. 20A) indicating that TLR2 is the main receptor triggering this response. TLR2 
can act in synergism with other TLRs, and since mtROS production was not completely 
abolished in TLR2-deficient macrophages, I next used macrophages deficient for the TLR 
adaptor molecule MyD88. MyD88 is required for all TLRs except TLR3 and (partly) TLR4 (Ley 
et al., 2016), which allowed me to test if other TLRs contribute to induction of mtROS 
production. In MyD88-deficient macrophages, mtROS production was not induced by L.m. 
infection at all (Fig. 20B). Notably, the same was true in macrophages deficient for the signaling 
transducer TRAF6 (Fig. 20C), which functions as an accumulation point for signals coming from 
all TLRs. Pro-inflammatory cytokine secretion after L.m. infection was significantly reduced in 
TLR2-deficient (Fig. 20D) and even more reduced in MyD88- (Fig. 20E) and TRAF6-deficient 
macrophages (Fig. 20F). 
Collectively, the data from this section show that mtROS production is not caused by 
mitochondrial perturbation. Instead, mtROS production and pro-inflammatory cytokine secretion 
are predominantly triggered via the TLR2/MyD88/TRAF6 signaling pathway in L.m.-infected 
macrophages. 
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Figure 20: mtROS production in infected macrophages is induced by TLR2/MyD88/TRAF6 signaling 
(Legend on next page) 
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Figure 20 (continued): mtROS production in infected macrophages is induced by TLR2/MyD88/TRAF6 
signaling 
(A-C) Macrophages were infected with L.m. at a MOI of 1. The kinetics of ROS production and the area under the 
curve (AUC), as a measure for the total amount of ROS produced, are shown. Cytosolic ROS production by WT or 
TLR2-KO, MyD88-KO and TRAF6-KO macrophages was quantified by measuring DCF fluorescence (n=7, 7 and 6, 
respectively). 
(D-F) Macrophages were infected with L.m. at a MOI of 1 for 5 hours. Secretion of IL-1β, IL-6 and TNF by WT or 
TLR2-KO, MyD88-KO, TRAF6-KO macrophages was quantified by ELISA (n=5, 3 and 4, respectively). 
 
3.4. Modulation of pro-inflammatory signaling pathways by mtROS 
As secretion of pro-inflammatory cytokines depended on TLR/MyD88/TRAF6 signaling and 
mtROS production, I investigated in more detail which pro-inflammatory signaling pathways are 
modulated by mtROS in infected macrophages. The main pathways initiated by 
TLR/MyD88/TRAF6 signaling are the ERK1/2, JNK1/2 and p38 MAPK pathways and the 
pathways leading to activation of NF-κB (Arthur et al., 2013; Newton et al., 2012). 
3.4.1. mtROS are crucial for activation of the ERK1/2 pathway 
All three investigated terminal kinases of the main MAPK pathways, namely ERK1/2, JNK1/2 
and p38, were activated in L.m.-infected macrophages with strongest phosphorylation after 30 
min (Fig. 21A). Phosphorylation of JNK1/2 was only slightly decreased and phosphorylation of 
p38 remained unchanged after global scavenging of ROS with NAC or by inhibiting mtROS 
production with rotenone (Fig. 21A). Importantly, both treatments strongly reduced 
phosphorylation of ERK1/2 and its upstream regulator kinase MEK1/2 (Fig. 21A) indicating that 
mtROS production is crucial for the activation of the MAPK ERK1/2 in infected macrophages. 
Since mtROS production was crucial for both cytokine secretion and ERK1/2 activation, I used 
the MEK1/2-specific inhibitor PD98059 to investigate the role of ERK1/2 in pro-inflammatory 
cytokine secretion by L.m.-infected macrophages. Notably, treatment of infected macrophages 
with PD98059 resulted in a strongly reduced secretion of IL-1β and IL-6, while TNF was 
significantly reduced (Fig. 21B). These data indicate that mtROS are crucial for activation of the 
ERK1/2 pathway that is necessary for pro-inflammatory cytokine secretion. 
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Figure 21: mtROS are crucial for activation of the ERK1/2 pathway 
(A) At the indicated time points after infection with L.m. at a MOI of 1 in the presence or absence of 50 mM NAC or 
100 µM rotenone, phosphorylation status of MEK1/2 (n=6), ERK1/2 (n=3), JNK1/2 (n=7) and p38 (n=8) were 
analyzed by Western blot and quantified by densitometry of band intensities. 
(B) Secretion of IL-1β, IL-6 and TNF after 5 hours of infection with L.m. at a MOI of 1 in the presence or absence of 
20 µM PD98059 was quantified by ELISA (n=3) 
(C) Viability of macrophages after infection at a MOI of 1 for 5 hours in the presence or absence of 20 µM PD98059 
(n=3). 
 
 
p-M E K1/2
0 .0
0 .2
0 .4
0 .6
0 .8
1 .0
1 .2
tim e afte r infection (m in)
b
a
n
d
 i
n
te
n
s
it
y
 (
n
o
rm
a
li
z
e
d
 t
o
 a
c
ti
n
)
3 0  6 0 1 2 0 3 0 0
****
**** **
**
0
p-ER K1/2
0 .0
0 .2
0 .4
0 .6
0 .8
1 .0
1 .2
1 .4
tim e afte r infection (m in)
3 0  6 0 1 2 0 3 0 0
***
**
**
****
0
p-ER K1/2
0 .0
0 .2
0 .4
0 .6
0 .8
1 .0
1 .2
1 .4
tim e afte r infection (m in)
3 0  6 0 1 2 0 3 0 0
**
ns
*
**
0
untreated + NAC 
time p.i. (min) 
p-ERK1/2 
p-JNK1/2 
p-p38 
0 30 60 120 300 
+ rotenone 
0 30 60 120 300 0 30 60 120 300 
p-p38
0 .0
0 .2
0 .4
0 .6
0 .8
1 .0
1 .2
1 .4
tim e afte r infection (m in)
3 0  6 0 1 2 0 3 0 00
ns ns
ns
ns
p-p38
0 .0
0 .2
0 .4
0 .6
0 .8
1 .0
1 .2
1 .4
tim e afte r infection (m in)
3 0  6 0 1 2 0 3 0 00
ns
ns
ns ns
p-JN K 1/2
0 .0
0 .5
1 .0
1 .5
2 .0
2 .5
tim e afte r infection (m in)
3 0  6 0 1 2 0 3 0 0
**
ns
0
ns
ns
p-JN K 1/2
0 .0
0 .5
1 .0
1 .5
2 .0
2 .5
tim e afte r infection (m in)
3 0  6 0 1 2 0 3 0 0
***
**
ns
0
ns
untreated 
NAC 
untreated 
rotenone 
β-actin 
p-MEK1/2 
p-M E K1/2
0 .0
0 .2
0 .4
0 .6
0 .8
1 .0
1 .2
tim e afte r infection (m in)
b
a
n
d
 i
n
te
n
s
it
y
 (
n
o
rm
a
li
z
e
d
 t
o
 a
c
ti
n
)
3 0  6 0 1 2 0 3 0 0
***
**
**
0
**
Figure 21 
A 
0
5 0 0
1 0 0 0
1 5 0 0
T
N
F
 (
p
g
/m
l)
L.m.n.i.
*
n .d .
0
5 0 0
1 0 0 0
1 5 0 0
IL
-6
 (
p
g
/m
l)
L.m.n.i.
**
n .d .
0
5 0 0
1 0 0 0
1 5 0 0
2 0 0 0
IL
-1

 (
p
g
/m
l)
L.m.n.i.
**
n .d .
untreated 
PD98059 
C 
0
2 0
4 0
6 0
8 0
1 0 0
1 2 0
V
ia
b
le
 c
e
ll
s
 (
%
 o
f 
n
.i
.)
L.m.n.i.
ns
ns
untreated 
PD98059 
B 
3. Results 
56 
 
3.4.2. mtROS are necessary for full activation of NF-κB signaling 
MAPK regulate cytokine secretion in conjunction with the NF-κB pathway (Gantke et al., 2012). 
Degradation of IκBα, a prerequisite for release of NF-κB and phosphorylation of the NF-κB 
subunit p65, which is necessary for optimal induction of NF-κB target genes (Christian et al., 
2016), were initiated in L.m.-infected macrophages (Fig. 22A). While IκBα degradation was not 
reduced after global scavenging of ROS with NAC or rotenone-induced mtROS deficiency, both 
treatments led to a premature terminated phosphorylation of NF-κB p65 (Fig. 22A). Moreover, 
translocation of NF-κB into the nucleus was strongly reduced (Fig. 22B) and binding of NF-κB to 
DNA was nearly abrogated in mtROS-deficient macrophages (Fig. 22C). 
Collectively, the data from this section show that mtROS are crucial for activation of the ERK1/2 
and NF-κB pathway and both signaling pathways contribute to subsequent pro-inflammatory 
cytokine secretion by infected macrophages. 
3. Results 
57 
 
 
Figure 22: mtROS are necessary for full activation of NF-κB signaling 
(A) At the indicated time points after infection with L.m. at a MOI of 1 in the presence or absence of 50 mM NAC or 
100 µM rotenone, phosphorylation status of NF-κB p65 (n=6), and degradation of IκBα (n=7) were analyzed by 
Western blot and quantified by densitometry of band intensities. 
(B) At the indicated time points after infection with L.m. at a MOI of 1 in the presence or absence of 50 mM NAC or 
100 µM rotenone, macrophages showing translocation of NF-κB p65 into the nucleus were quantified by 
immunofluorescence microscopy (n=4). Scale bar represents 4 µm. 
(C) At 1 hour after infection with L.m. at a MOI of 1 in the presence or absence of 50 mM NAC or 100 µM rotenone, 
DNA binding of NF-κB was analyzed by EMSA and quantified by densitometry of band intensities (n=3). 
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3.5. Mechanisms of mtROS-dependent pro-inflammatory signaling 
Several studies addressed the question how ROS could influence pathways leading to cytokine 
secretion. Oxidative inhibition of phagosomal cathepsins (Allan et al., 2014; Deffert et al., 2012) 
or redox-sensitive phosphatases (Bulua et al., 2011a; Rao et al., 2002; Meinhard et al., 2001) 
have been suggested as possible targets for ROS. 
3.5.1. mtROS do not regulate cytokine secretion by oxidative phosphatase 
inactivation 
The phosphorylation status of IKKβ, as well as that of several other kinases involved in pro-
inflammatory signaling, is determined by the relative activities of upstream kinases and specific 
phosphatases such as PP2A and PP2Cβ (Hinz et al., 2014). Like many other phosphatases, 
PP2A are sensitive to oxidative inactivation (Rao et al., 2002; Meinhard et al., 2001), which 
favors phosphorylation of their substrates. Therefore, I investigated if oxidative inactivation of 
phosphatases by mtROS is required for pro-inflammatory signaling leading to cytokine secretion 
by L.m.-infected macrophages. To this end, I analyzed whether phosphatase inhibition could 
rescue impaired cytokine secretion by mtROS-deficient macrophages. Neither inhibition of 
protein tyrosine phosphatases with orthovanadate or PTP inhibitor I nor inhibition of 
serine/threonine phosphatases with okadaic acid, calyculin A, tautomycin or sanguinarine could 
rescue cytokine secretion by mtROS-deficient macrophages (Fig. 23). Thus, mtROS do not 
regulate pro-inflammatory signaling in L.m.-infected macrophages by inactivating redox-
sensitive phosphatases. 
 
Figure 23: mtROS do not regulate cytokine secretion by oxidative phosphatase inactivation 
Secretion of IL-1β, IL-6 and TNF after 5 hours of infection with L.m. at a MOI of 1 in the presence or absence of 50 
mM NAC or 100 µM rotenone and with the inhibitors for protein tyrosine phosphatases (PTPs) orthovanadate (1 
µM) (all PTPs), PTP-inhibitor I (5 µM) (PTP-1B and SHP-1) or for serine/threonine phosphatases (PPs) okadaic 
acid (1.5 nM) (PP1s and PP2As), calyculin A (100 µM) (PP1s and PP2A-C), tautomycin (10 nM) (PP1s and PP2As) 
or sanguinarine (1 nM) (PP2Cs) was quantified by ELISA (n=3). 
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3.5.2. mtROS are crucial for IKK complex activation 
Both the ERK1/2 and the NF-κB pathway are initiated via the IKK complex (Gantke et al., 2012; 
Mercurio et al., 1997), whereas JNK1/2 and p38 pathways are activated independently of the 
IKK complex (Arthur et al., 2013; Israel, 2010; Sato et al., 2005; Shim et al., 2005). IKK complex 
activation leads to phosphorylation of IKKα/IKKβ that is essential for subsequent pro-
inflammatory signaling. Importantly, L.m. infection of macrophages resulted in phosphorylation 
of IKKβ that was strongly reduced after treatment with NAC and rotenone (Fig. 24A) indicating 
that activation of the IKK complex requires mtROS-dependent signals. 
3.5.3. mtROS induce covalent linkage of NEMO via disulfide bonds 
An important regulator of IKK complex activation is its subunit NEMO. Function and structures 
of NEMO were investigated either with ligands that activate only one specific signaling pathway 
(Scholefield et al., 2016; Xu et al., 2009) or in infected non-immune cells (Brady et al., 2017). 
The structural and post-translational modifications as well as the role of NEMO during bacterial 
infection in immune cells in general and macrophages in particular remained completely elusive. 
NEMO molecules have been shown to be covalently linked by ROS-depended disulfide linkage 
in mouse embryonic fibroblasts (MEFS) (Herscovitch et al., 2008a) and, moreover, covalent 
disulfide linkage stabilized recombinant NEMO protein and increased its affinity to IKKβ in vitro 
(Zhou et al., 2014b). Therefore, NEMO disulfide linkage is a promising potential target for 
mtROS-dependent regulation of pro-inflammatory signaling in infected macrophages. 
To analyze the possible role of mtROS-dependent regulation of NEMO in infected 
macrophages, I used non-reducing SDS-PAGE under conditions that disrupt non-covalent 
interactions but preserve covalent links such as disulfide bonds (see section 2.2.14.2 and also 
(Herscovitch et al., 2008a). Uninfected macrophages contained only monomeric NEMO (~55 
kDa), whereas L.m.-infection resulted in recruitment of NEMO into a complex of approximately 
200 kDa (Fig. 24B). The other components of the IKK complex, IKKα and IKKβ, were not 
included in the NEMO complex (Fig. 24B). Under standard reducing Western Blot conditions, 
which also disrupt covalent disulfide bonds, the NEMO complex was completely degraded to 
monomeric NEMO, but could be preserved by post-lysis protein crosslinking (Fig. 24C). Notably, 
even after crosslinking, uninfected macrophages contained only monomeric NEMO indicating 
that the NEMO complex is not present in naïve macrophages but forms after infection by 
covalent disulfide linkage. Importantly, covalent NEMO complex formation after L.m.-infection 
was strongly reduced in mtROS-deficient macrophages (Fig. 24D). These data show that, upon 
infection, NEMO is recruited into a complex, which is covalently linked via disulfide bonds and, 
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moreover, that mtROS are crucial for formation of this NEMO complex and subsequent IKKβ 
activation. 
 
Figure 24: mtROS are crucial for covalent linkage of NEMO via disulfide bonds and subsequent IKK 
complex activation 
(A) At the indicated time points after infection with L.m. at a MOI of 1 in the presence or absence of 50 mM NAC or 
100 µM rotenone, phosphorylation status of IKKβ was analyzed by Western blot and quantified by densitometry of 
band intensities (n=6). 
(B) At the indicated time points after infection with L.m. at a MOI of 1 presence of IKKα and IKKβ in the covalently 
linked NEMO complex was analyzed by non-reducing SDS-PAGE and Western blot (n=3) (continued on next 
page). 
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Figure 24 (continued): mtROS are crucial for covalent linkage of NEMO via disulfide bonds and subsequent 
IKK complex activation 
(C) Covalent linkage of NEMO via disulfide bonds was stabilized by amine-to-amine cross-linking with BS3 after 30 
min infection with L.m. at a MOI 1 and analyzed by standard reducing SDS-PAGE and Western Blot and quantified 
by densitometry of band intensities (n=5). 
(D) At the indicated time points after infection with L.m. at a MOI of 1 in the presence or absence of 100 µM 
rotenone, covalent linkage of NEMO via disulfide bonds was analyzed by non-reducing SDS-PAGE and Western 
blot and quantified by densitometry of band intensities (n=3). 
 
3.5.4. mtROS induce NEMO complex formation by covalent linkage via Cys54 
and Cys347 
Herscovitch et al. identified the two redox-sensitive cysteines Cys54 and Cys347 to be necessary 
for covalent dimerization of NEMO via disulfide bonds (Herscovitch et al., 2008a). I 
hypothesized, that infection-induced mtROS induce NEMO complex formation by covalent 
linkage of Cys54 and Cys347. To test this, I expressed a NEMO mutant in macrophages (Fig. 
25A-B), in which Cys54 and Cys347 are mutated to alanine (NEMOC54/347A) and that therefore 
cannot form disulfide-linked dimers (Herscovitch et al., 2008a). Importantly, the transfected 
NEMOC54/347A construct was not able form covalently linked complexes in macrophages at all 
(Fig. 25C). Since two NEMO molecules with functional cysteine residues have to pair up to form 
disulfide bonds, expression of the NEMOC54/347A mutant strongly impaired NEMO complex 
formation in infected macrophages (Fig. 25D). Together, these data show that mtROS produced 
in response to L.m. infection induce covalent linkage of NEMO via Cys54/347. 
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Figure 25: mtROS induce NEMO complex formation by covalent linkage via Cys
54
 and Cys
347 
(A-D) Macrophages were transfected with mRNA encoding for wildtype NEMO (NEMO
Wt
) or a NEMO mutant in 
which redox-sensitive Cys
54
 and Cys
347
 are mutated to alanine (NEMO
C54/347A
) for 6 h. 
(A) Transfection rate was quantified by immunofluorescence microscopy (n=4). 
(B) Expression levels of endogenous NEMO (n=5) and exogenous FLAG-tagged NEMO constructs (n=3) were 
analyzed by Western blot and quantified by densitometry of band intensities. 
(C) At the indicated time points after infection with L.m. at a MOI of 1 covalent linkage of exogenous NEMO
Wt
 and 
NEMO
C54/347A
 constructs via disulfide bonds was analyzed by non-reducing SDS-PAGE and Western blot and 
quantified by densitometry of band intensities (n=3). 
(D) At the indicated time points after infection with L.m. at a MOI of 1 covalent linkage of NEMO via disulfide bonds 
was analyzed by non-reducing SDS-PAGE and Western blot and quantified by densitometry of band intensities 
(n=5). 
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3.5.5. mtROS-mediated covalent linkage of NEMO via Cys54 and Cys347 is 
crucial for pro-inflammatory signaling 
I next wanted to investigate, if mtROS-dependent covalent linkage of NEMO via Cys54 and 
Cys347 is the mechanistic step, which licenses pro-inflammatory signaling in infected 
macrophages. Strikingly, similar to mtROS-deficiency, expression of the NEMOC54/347A mutant 
specifically reduced IKKβ and ERK1/2 phosphorylation (Fig. 26A), DNA binding of NF-κB (Fig. 
26B) and pro-inflammatory cytokine secretion in L.m.-infected macrophages (Fig. 26C). These 
data show that mtROS regulate IKK complex activation as well as subsequent pro-inflammatory 
signaling and cytokine secretion by inducing covalent disulfide linkage of NEMO via Cys54/347. 
 
Figure 26: mtROS-mediated covalent linkage of NEMO via Cys
54
 and Cys
347
 is crucial for pro-inflammatory 
signaling (legend on next page) 
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(A-C) Macrophages were transfected with mRNA encoding for wildtype NEMO (NEMO
Wt
) or a NEMO mutant in 
which redox-sensitive Cys
54
 and Cys
347
 are mutated to alanine (NEMO
C54/347A
) for 6 h. 
(A) At the indicated time points after infection with L.m. at a MOI of 1 phosphorylation of IKKβ, ERK1/2, JNK1/2, 
p38 and NF-κB p65 and degradation of IκBα was analyzed by Western blot and quantified by densitometry of band 
intensities (n=3). 
(B) At 1 hour after infection with L.m. at a MOI of 1 DNA binding of NF-κB was analyzed by EMSA and quantified 
by densitometry of band intensities (n=3). 
(C) Secretion of IL-1β, IL-6 and TNF after 5 hours of infection with L.m. at a MOI of 1 was quantified by ELISA 
(n=3). 
 
3.5.6. mtROS do not regulate processes up- or downstream of NEMO 
If regulation of pro-inflammatory signaling leading to cytokine secretion by mtROS was 
exclusively by licensing activation of the IKK complex via disulfide linkage of NEMO, up- and 
downstream processes should not be affected by mtROS deficiency. The signaling cascade 
initiating IKK complex activation involves a complex consisting of MyD88, IRAK4, IRAK1/2 and 
TRAF6. IRAK1 is degraded shortly after activation of the IKK complex (Muroi et al., 2012; 
Yamin et al., 1997). IRAK1 degradation was induced in L.m.-infected macrophages and was not 
impaired by treatment with NAC or rotenone (Fig. 27A) suggesting that processes upstream of 
IKK complex activation do not depend on mtROS. Activation of IKKβ was strongly dependent on 
mtROS-mediated NEMO complex formation (Fig. 24B). Therefore, expression of a constitutively 
active IKKβ mutant (caIKKβ) (Mercurio et al., 1997) should allow cytokine secretion even in the 
absence of mtROS production because it bypasses the redox-sensitive step of NEMO complex 
formation. Interestingly, expression of caIKKβ (Fig. 27B+C) alone was not sufficient to induce 
MAPK- or NF-κB-pathways (Fig. 27D) or cytokine secretion (Fig. 27E). An additional stimulus 
such as L.m. infection or LPS treatment was necessary to activate pro-inflammatory signaling. 
Notably, expression of caIKKβ rescued pro-inflammatory cytokine secretion in macrophages 
deficient for ROS in general or mtROS in particular (Fig. 27E) indicating that mtROS are not 
required for processes downstream of IKK complex activation. 
Collectively, the data from this section indicate that mtROS produced in response to L.m. 
infection license activation of the IKK complex and subsequent signaling via the ERK1/2 and 
NF-κB pathways leading to cytokine secretion by inducing intermolecular disulfide linkage of 
NEMO via the redox-sensitive cysteines Cys54/347 
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Figure 27: mtROS do not regulate processes up- or downstream of NEMO (Figure continued on next page) 
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Figure 27 (continued): mtROS do not regulate processes up- or downstream of NEMO 
(B-E) Macrophages were transfected with mRNA encoding for wildtype IKKβ (wtIKKβ) or a constitutively active 
IKKβ mutant (caIKKβ) for 6 h. 
(A) At the indicated time points after infection with L.m. at a MOI of 1 in the presence or absence of 50 mM NAC or 
100 µM rotenone, degradation of IRAK1 was analyzed by Western blot and quantified by densitometry of band 
intensities (n=3). 
(B) Transfection rate was quantified by immunofluorescence microscopy (n=2). 
(C) Expression levels of FLAG-tagged IKKβ were analyzed by Western blot and quantified by densitometry of band 
intensities (n=4). 
(D) Phosphorylation status of ERK1/2, JNK1/2, p-p38 and NF-κB p65 and degradation of IκBα after infection with 
L.m. at a MOI of 1 for 30 min was analyzed by Western blot and quantified by densitometry of band intensities 
(n=3). 
(E) Secretion of IL-1β, IL-6 and TNF after 5 hours of infection with L.m. at a MOI of 1 or treatment with 5 µg/ml LPS 
and in the presence or absence of 50 mM NAC or 100 µM rotenone was quantified by ELISA (n=3). 
 
3.5.7. Mechanism for mtROS-mediated pro-inflammatory signaling in 
infected macrophages 
Based on the data described in this thesis I propose the following model for regulation of pro-
inflammatory cytokine secretion by mtROS in L.m.-infected macrophages (Fig. 28): (1) 
Recognition of L.m. by TLR2 (in conjunction with other MyD88-dependent TLRs) induces 
activation of IRAK1/2 and TRAF6. (2) TRAF6 induces mtROS production. mtROS are produced 
as .O2
- into the IMS by complex III of the ETC and converted into H2O2 by SOD1 allowing them 
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to access the cytosol by diffusion. (3) In the cytosol, mtROS mediate intermolecular covalent 
linkage of NEMO via disulfide bonds formed by the redox-sensitive cysteines Cys54 and Cys347A, 
which (4) allows full assembly and activation of the IKK complex. (5) Finally, the fully assembled 
IKK complex activates the ERK1/2 and NF-κB pathways resulting in pro-inflammatory cytokine 
secretion. I thus identify mtROS-dependent disulfide linkage of NEMO as an essential 
regulatory step of the pro-inflammatory response of macrophages to bacterial infection. 
Figure 28 
 
Figure 28: Model for regulation of pro-inflammatory cytokine secretion by mtROS in L.m.-infected 
macrophages 
Detailed description can be found in the text. 
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4. Discussion 
ROS have been reported to act in a number of different signaling pathways. However, the 
sources of ROS as well as the signaling pathways that are regulated by them largely depend on 
the specific cell type and stimulus (Holmström et al., 2014; Nathan et al., 2013b). Although ROS 
are clearly involved in cellular signaling processes on organ, tissue and cellular levels (Singel et 
al., 2016), surprisingly little is known about the molecular processes or proteins through which 
ROS influence pro-inflammatory signaling in general and during bacterial infection of 
macrophages in particular. 
In this thesis, I used L.m. infection of peritoneal macrophages to model the anti-bacterial 
response of tissue macrophages to a complex pathogenic stimulus in order to investigate the 
cellular sources of ROS required for cytokine secretion and the molecular targets of ROS-
dependent regulation of the pro-inflammatory response.  
4.1. Mechanisms of ROS production in infected macrophages 
Sources, locations, subspecies, quantities and specific roles of ROS vary greatly in dependency 
of the stimulus and the organ, tissue or cell type investigated. Therefore, consideration and 
definition of all these factors in each study that involves ROS as main research topic is essential 
to gain new mechanistic insights into ROS-dependent signaling. I used a respective panel of 
ROS detection probes, various knockout and knockin mouse lines and chemical inhibitors to 
define the source, subcellular locations and subspecies of ROS that play a role in pro-
inflammatory signaling during bacterial infection of macrophages. 
4.1.1 ROS production by Nox enzymes 
Since the NADPH oxidase Nox2 is the predominant source of ROS in phagocytes, including 
macrophages, (Singel et al., 2016; Segal et al., 1981), Nox2-derived ROS often take center 
stage in the anti-microbial response of macrophages (Gluschko and Herb et al., 2018; Herb et 
al., 2018; Schramm et al., 2014; Pizzolla et al., 2012; Cornish et al., 2008; Gelderman et al., 
2007). Upon stimulation, phagocytes produce robust quantities of Nox2-derived ROS into the 
extracellular space (Gluschko and Herb et al., 2018; Mocsai et al., 2002; Segal et al., 1981). 
Accordingly, macrophages showed a robust extracellular ROS production after bacterial 
infection and these extracellular ROS were exclusively produced by Nox2.  
Recently, activation of Nox4 as a cytosolic ROS source after Toxoplasma gondii infection was 
described in BMDM (Kim et al., 2017). However, cytosolic ROS production by L.m.-infected 
macrophages was completely independent not only of Nox2 but also of all other isoforms of the 
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Nox/Duox family, namely Nox1, Nox4, Duox1 and Duox2. Even deficiency for the catalytic 
subunit p22phox, which is essential for Nox1-4 did not alter infection-induced cytosolic ROS 
production. Of course, Toxoplasma gondii, as a eukaryotic parasite might trigger other ROS 
sources than bacterial infection. Moreover, BMDM have been described as not fully matured 
macrophages, expressing, for example, completely different surface receptors than mature 
tissue macrophages such as peritoneal or splenic macrophages (Wang et al., 2013; Murray et 
al., 2011). In addition, we could recently show that Nox2-derived extracellular ROS production 
in L.m.-infected BMDM was strongly reduced in comparison to peritoneal macrophages due to 
lower protein levels of Nox2 (Gluschko and Herb et al., 2018). Therefore, it is not surprising that 
ROS sources and quantities vary between cell types and stimuli. My data clearly define Nox2 as 
the exclusive extracellular ROS source, whereas cytosolic ROS production was completely 
independent of Nox/Duox family members after bacterial infection of tissue macrophages. 
4.1.2 ROS production by mitochondria 
Surprisingly, I identified mitochondria as the source of cytosolic ROS produced by macrophages 
after bacterial infection. Several studies showed that stimuli associated with Gram-negative 
pathogens induce mtROS production into the mitochondrial matrix (Garaude et al., 2016; West 
et al., 2011a). My data show that L.m. infection did not induce measurable production of ROS 
into the mitochondrial matrix and that matrix-derived ROS did not contribute to cytosolic ROS 
levels, since neither scavenging of .O2
- nor that of H2O2 in the mitochondrial matrix did alter 
cytosolic ROS levels. Instead, blockade of electron flow from complex I to complex III with 
rotenone almost completely abrogated cytosolic ROS production. Complex III can produce ROS 
not only into the mitochondrial matrix but also into the IMS (Lanciano et al., 2013; West et al., 
2011b; Murphy, 2009; Fridovich, 1997). Accordingly, inhibition of electron flow from complex III 
to complex IV with antimycin A (Bleier et al., 2013; Park et al., 2007) strongly increased 
cytosolic ROS levels not only in infected but also in uninfected macrophages indicating that 
complex III of the mitochondrial ETC produces ROS directly into the IMS. While .O2
- needs 
VDAC to cross the outer mitochondrial membrane (Shoshan-Barmatz et al., 2010), H2O2 can 
reach the cytosol by diffusion from the IMS. Scavenging of cytosolic .O2
- did not reduce cytosolic 
ROS levels, but scavenging of cytosolic H2O2 strongly reduced cytosolic ROS production in 
infected macrophages, identifying H2O2 as the cytosolic ROS subspecies produced by 
mitochondria. 
Notably, inhibition of complex II did not alter cytosolic ROS levels. This is particularly interesting 
since BMDM challenged with the Gram-negative bacterium Escherichia coli transiently switch 
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the relative contributions to mitochondrial respiration from complex I to complex II by 
destabilization of complex I (Garaude et al., 2016). This rearrangement of the ETC depends on 
recognition of RNA from live bacteria by TLR3 and TLR7 and on phagosomal ROS production 
by Nox2 (Garaude et al., 2016). My data argue against a similar role for complex II in cytosolic 
ROS production during Gram-positive infection because 1) inhibition of complex II with 
malonate did not alter cytosolic ROS levels and 2) cytosolic ROS production was completely 
independent of Nox2, whereas electron transfer from complex I to complex III was essential for 
cytosolic ROS production. Thus, my data reveal a clear distinction to Gram-negative pathogens 
in the location of cytosolic ROS production by mitochondria indicating different mitochondrial 
targets for the signals induced by Gram-positive and Gram-negative pathogens.  
Taken together, I identified two subcellular distinct ROS sources that contribute to ROS 
production in infected macrophages. On the one hand Nox2, as the exclusive extracellular ROS 
source, and on the other hand, complex III of the mitochondrial ETC that produces mtROS 
directly into the IMS from where they reach the cytosol as H2O2. 
4.2 Induction of mtROS production 
Several studies addressed the question which stimuli and signaling pathways induce ROS 
production in macrophages and induction of Nox2-dervied ROS production is well-characterized 
for a broad spectrum of Gram-positive and Gram-negative pathogens and associated PAMPs 
(Remer et al., 2005; Werling et al., 2004; Vazquez-Torres et al., 2001; Adachi et al., 1998). We 
recently identified the β2 integrin Mac-1 as an important receptor for L.m.-induced Nox2-derived 
phagosomal ROS production, which was crucial for listerial clearance in vivo (Gluschko and 
Herb et al., 2018; Herb et al., 2018). So far, studies that investigated induction of mtROS only 
used infection models with Gram-negative bacteria (Bulua et al., 2011a; West et al., 2011a) or 
LPS as a PAMP associated with Gram-negative bacteria (Kelly et al., 2015; Chandel et al., 
2000). If and how Gram-positive pathogens such as L.m. stimulate mtROS in immune cells 
remained unknown. 
4.2.1 Stress-induced mtROS production 
Perturbation of mitochondrial function can result in increased mitochondrial ROS production 
(Zhang et al., 2016; Motori et al., 2013; Detmer et al., 2007). Stavru et al. reported that L.m. 
uses its pore-forming toxin LLO to induce fragmentation of the mitochondrial network in HeLa 
cells (Stavru et al., 2011). Therefore, I investigated if mtROS production in L.m.-infected 
macrophages was caused by LLO-dependent mitochondrial perturbation. L.m. deficient for LLO 
(Δhly) or for the transcriptional master regulator of L.m. virulence factors, prfA (ΔprfA), induced 
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mtROS production to a similar level as wild type L.m. excluding a role for L.m. virulence factors 
in induction of mtROS. Furthermore, the mitochondrial network was not fragmented and the 
mitochondrial membrane potential, an indicator of mitochondrial health, was not reduced in 
L.m.-infected macrophages. Thus, L.m. infection induces mtROS production in macrophages 
not by damaging the mitochondrial network. 
4.2.2 Receptor-induced mtROS production 
mtROS production into the mitochondrial matrix was shown to be induced by infection with 
Salmonella typhimurium (West et al., 2011a). The signaling cascade leading to mtROS 
production into the mitochondrial matrix involves the TLR4/MyD88/TRAF6 signaling pathway 
and the protein ECSIT (Carneiro et al., 2018; West et al., 2011a; Vogel et al., 2007). Therefore, 
I investigated if L.m. infection induces mtROS production in an analogous manner via TLR2 
signaling. Production of mtROS after L.m. infection was nearly abrogated in TLR2-, MyD88- and 
TRAF6-deficient macrophages indicating that mtROS production by L.m.-infected macrophages 
is predominantly triggered via the TLR2/MyD88/TRAF6 signaling pathway. 
These data indicate that mtROS production in L.m.-infected macrophages is actively induced by 
TLR2/MyD88/TRAF6 signaling and not caused by perturbation of mitochondria. 
4.3. Role of ROS for pro-inflammatory cytokine secretion 
The role of ROS in the pro-inflammatory response of macrophages to infection with pathogenic 
bacteria in general or to L.m. in particular is incompletely understood (Brune et al., 2013; 
Forman et al., 2002). Global scavenging of ROS with NAC in infected macrophages resulted in 
strong reduction of the three pro-inflammatory cytokines IL-6, TNF and IL-1β, suggesting an 
important role for ROS in general for pro-inflammatory signaling during bacterial infection. Since 
NAC scavenges both, extracellular and intracellular ROS, I investigated, which of the infection-
induced subcellular ROS sources, namely Nox2 (extracellular ROS) or mitochondria (cytosolic 
mtROS), are necessary for pro-inflammatory signaling in macrophages. 
4.3.1 Role of Nox/Duox enzymes for pro-inflammatory cytokine secretion 
Deficiency for Nox2 leads to a hyper-inflammatory phenotype in mice (Grimm et al., 2013; 
Brown et al., 2003) accompanied by elevated cytokine levels (Allan et al., 2014; Deffert et al., 
2012). Furthermore, redox-sensitiv activation of the transcription factor NF-κB in a Nox2-
dependent manner during LPS-induced lung inflammation was reported (Han et al., 2013). 
These studies suggest a regulatory role for Nox2-derived ROS in the pro-inflammatory 
response. However, while IL-1β secretion was even enhanced in Nox2- and p22phox-deficient 
macrophages after L.m. infection, secretion of IL-6 and TNF was unaltered indicating that Nox2-
4. Discussion 
72 
 
dervied extracellular ROS are dispensable for cytokine secretion in infected macrophages. By 
contrast, further elimination of intracellular ROS by treatment of Nox2-deficient macrophages 
with NAC strongly reduced cytokine levels to a similar degree as in WT macrophages 
suggesting a crucial role for intracellular ROS during pro-inflammatory cytokine secretion. Since 
Nox1-4 and Duox1-2 did not contribute to cytosolic ROS production, macrophages deficient for 
these Nox isoforms also did not show any reduction in cytokine levels indicating that Nox/Duox 
enzymes do not contribute to cytosolic ROS production necessary for pro-inflammatory 
signaling in infected macrophages. 
4.3.2 Role of mtROS for pro-inflammatory cytokine secretion 
mtROS production into mitochondrial matrix was reported to be necessary for pro-inflammatory 
cytokine secretion after LPS stimulation (Kelly et al., 2015; Bulua et al., 2011b), but not after 
infection with the Salmonella typhimurium (West et al., 2011a). L.m.-infection did not induce 
mtROS production into the mitochondrial matrix. Furthermore, scavenging of .O2
- and H2O2 in 
the mitochondrial matrix did not reduce pro-inflammatory cytokine secretion indicating that 
matrix-derived ROS do not contribute to cytosolic ROS levels and do not play a role in pro-
inflammatory signaling in L.m.-infected macrophages. This is in accordance with the data from 
West et al. (bacterial infection) but differs from the study of Bulua et al. (stimulation with LPS). 
Recognition and phagocytosis of pathogenic bacteria such as L.m. and Salmonella typhimurium 
provide much more complex and sustained signals induced by several receptors than activation 
of a single type of receptor with a distinct stimulus such as LPS as they simultaneously activate 
multiple signaling pathways. Therefore, it is reasonable, that bacterial infection of macrophages 
elicits multiple and more complex pro-inflammatory signaling pathways compared to stimulation 
with a distinct substance, such as LPS, and that the pathways differ in regulation. 
While L.m.-infection did not induce mtROS production into the mitochondrial matrix, it 
substantially induced mtROS production into the cytosol, which was nearly abolished after 
rotenone treatment of macrophages. Moreover, secretion of pro-inflammatory cytokines was 
strongly reduced in infected macrophages after rotenone treatment identifying infection-induced 
cytosolic mtROS production as crucial factor for pro-inflammatory cytokine secretion. Both H2O2 
and .O2
- can influence signaling pathways in cells (Holmström et al., 2014; Lambeth et al., 2014; 
Nathan et al., 2013a; Chen et al., 2009). Scavenging of cytosolic .O2
- did not reduce cytosolic 
ROS levels or pro-inflammatory cytokine secretion, excluding .O2
- as relevant signaling 
molecule for the pro-inflammatory response in L.m.-infected macrophages. Notably, scavenging 
of cytosolic H2O2 led not only to a strong reduction of cytosolic ROS levels but also to strong 
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reduction of IL-1β and IL-6 secretion and to a significant reduction of TNF secretion indicating 
that H2O2 is the signaling intermediate necessary for the pro-inflammatory response. SOD1, 
which is localized in the IMS and the cytosol, quickly dismutates .O2
- to H2O2. Accordingly, 
inhibition of SOD1 led to strongly reduced pro-inflammatory cytokine secretion in infected 
macrophages further strengthening the conclusion that H2O2 generated by complex III of the 
ETC is the ROS subspecies necessary for pro-inflammatory cytokine secretion. 
Taken together, I could show that Nox2-derived extracellular ROS are dispensable for cytokine 
secretion, but cytosolic ROS are crucial for this process. None of the Nox/Duox family members 
contribute to cytosolic ROS production or pro-inflammatory cytokine secretion after bacterial 
infection of macrophages. Surprisingly, cytosolic ROS are, in fact, produced by mitochondria 
(mtROS), but do not originate from the mitochondrial matrix. Instead, my data show L.m.-
infection induces TLR2/MyD88/TRAF6-dependent .O2
- production into the IMS by complex III of 
the ETC. Here, .O2
- is converted by SOD1 into H2O2 that diffuses into the cytosol where it 
regulates pro-inflammatory signaling. 
4.4 mtROS-dependent pro-inflammatory signaling pathways 
ROS act in a number of different signaling pathways (Holmström et al., 2014; Lambeth et al., 
2014). However, whether mtROS contribute to the pro-inflammatory response of macrophages 
remains an open question as several studies had used LPS as a Gram-negative associated 
PAMP to address this topic, but came to different and partly contrasting conclusions (Kelly et 
al., 2015; Bulua et al., 2011a; Chandel et al., 2000). mtROS produced into the mitochondrial 
matrix either were 1) required for TNF secretion upon hypoxia but not upon LPS-stimulation 
(Chandel et al., 2000), 2) led to increased IL-1β, unaltered TNF and decreased IL-10 secretion 
after LPS treatment (Kelly et al., 2015) or 3) partly reduced LPS-induced secretion of TNF, IL-6, 
IL-8 and IL-10 (Bulua et al., 2011a). If and how mtROS contribute to pro-inflammatory signaling 
in macrophages during infection with a Gram-positive pathogen remained completely elusive. 
The main pathways leading to production of cytokines in macrophages are the MAPK pathways 
and the pathways leading to activation of NF-κB (Arthur et al., 2013; Newton et al., 2012). 
Therefore, I investigated if these pathways are modulated by infection-induced mtROS 
production. 
4.4.1 MAPK-pathways 
Infection of macrophages with L.m. resulted in activation of all three MAPK pathways and their 
terminal kinases ERK1/2, JNK1/2 and p38. Importantly, preventing mtROS generation either by 
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scavenging of ROS with NAC or by inhibiting mtROS production with rotenone strongly reduced 
phosphorylation of ERK1/2 and its upstream regulator MEK1/2 indicating that mtROS are 
required for signaling via the ERK1/2 pathway. By contrast, phosphorylation of JNK1/2 was only 
slightly decreased and phosphorylation of p38 remained unchanged. Therefore, I hypothesized 
that the ERK1/2 pathway is the major pathway leading to secretion of cytokines by infected 
macrophages. Indeed, inhibition of the upstream kinase of ERK1/2, MEK1/2, was sufficient to 
completely block secretion of IL-1β and IL-6 and to significantly reduce TNF secretion. These 
data indicate that mtROS are required for pro-inflammatory signaling leading to cytokine 
secretion by infected macrophages mainly because they regulate signaling via the ERK1/2 
pathway. 
4.4.2 The NF-κB pathway 
MAPK regulate cytokine secretion in conjunction with the NF-κB pathway (Arthur et al., 2013; 
Newton et al., 2012; Chandrakesan et al., 2010). Degradation of IκBα a prerequisite for release 
of the p65 subunit of NF-κB, was not reduced in the absence of mtROS generation. However, 
phosphorylation of NF-κB p65, that is necessary for optimal induction of NF-κB target genes 
(Christian et al., 2016), translocation of NF-κB p65 from the cytosol into the nucleus as well as 
DNA binding of NF-κB were strongly reduced in the absence of mtROS generation indicating 
that mtROS also modulate signaling leading to activation of the NF-κB pathway. 
Thus, my data show that mtROS license pro-inflammatory signaling via activation the ERK1/2 
and NF-κB pathways in infected macrophages. 
4.5 The molecular target of mtROS-dependent pro-inflammatory 
signaling 
The molecular mechanisms by which mtROS regulate the pro-inflammatory response of 
macrophages during infection so far had remained completely unknown. Inactivation of redox-
sensitive phosphatases by mtROS has been suggested as a potential mechanism after LPS 
stimulation (Bulua et al., 2011b). Notably, in infected macrophages, inhibition of protein tyrosine 
phosphatases or serine/threonine phosphatases by a respective panel of inhibitors did not 
restore cytokine secretion during mtROS deficiency excluding this regulatory step as target for 
mtROS during bacterial infection. 
4.5.1 Activation of the IKK complex 
The ERK1/2 and the NF-κB pathways both depend on activation of the IKK complex (Ajibade et 
al., 2012; Gantke et al., 2012) and both pathways were not induced in mtROS-deficient 
macrophages. Therefore I analyzed, if mtROS deficiency during L.m. infection regulates IKK 
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complex activation. Notably, IKKβ phosphorylation, as the final step of IKK complex activation, 
was strongly reduced in mtROS-deficient macrophages. Rearrangement of the regulatory 
subunit NEMO is essential for assembly and phosphorylation of the IKKα/β subunits (Maubach 
et al., 2017; Scholefield et al., 2016). Moreover covalent disulfide bonds between NEMO 
monomers formed by the redox-sensitive cysteines Cys54 and Cys347 have been shown to 
stabilize the NEMO dimer and increase its affinity to IKKβ (Zhou et al., 2014b; Cote et al., 
2013b; Herscovitch et al., 2008a). Therefore, I hypothized, that redox-sensitive regulation of 
NEMO by mtROS is the underlying mechanistic step that licenses IKK activation and 
subsequent pro-inflammatory signaling in infected macrophages. 
4.5.2 Modulation of NEMO 
All studies that investigated NEMO structure and function so far used substances that only 
activate a single type of cellular receptor (e.g. LPS, IL-1β, TNF) (Scholefield et al., 2016; Xu et 
al., 2009; Herscovitch et al., 2008a; Windheim et al., 2008; Marienfeld et al., 2006), described 
the response of infected non-immune cells (Brady et al., 2017; de Jong et al., 2016; Wang et al., 
2012), or performed in vitro studies with recombinant NEMO protein (Zhou et al., 2014b; Cote et 
al., 2013b). Nearly nothing is known about the structure and post-translational modifications of 
NEMO in infected immune cells in general or in macrophages in particular. Therefore, this study 
investigated for the first time NEMO structure and modifications in infected immune cells. 
Uninfected macrophages contained only NEMO monomers that were not linked by covalent 
disulfide bonds. Notably, upon infection, NEMO was recruited into a covalently linked complex 
of approximately 200 kDa. The other subunits of the IKK complex than NEMO, IKKα and IKKβ, 
were not included in the covalently linked complex. Importantly, complex formation was nearly 
abrogated in mtROS-deficient macrophages The redox-sensitive residues Cys54 and Cys347 
have been shown to mediate disulfide linkage of NEMO monomers into a covalently linked 
dimer of about 100 kDa in TNF-stimulated non-immune cells (Zhou et al., 2014b; Cote et al., 
2013b; Herscovitch et al., 2008b). Indeed, solely preventing mtROS-mediated disulfide linkage 
of NEMO by expression of a NEMO construct in which the cysteines Cys54/347 are mutated to 
alanine (NEMOC54/374A) (Herscovitch et al., 2008a) was enough to abolish NEMO complex 
formation, IKKβ and ERK1/2 phosphorylation, DNA binding of NF-κB as well as pro-
inflammatory cytokine secretion in infected macrophages. 
Since the two cysteine residues Cys54/347 mediate formation of disulfide bonds between NEMO 
molecules (Zhou et al., 2014b; Cote et al., 2013b; Herscovitch et al., 2008a), and the other 
components of the IKK complex, IKKα and IKKβ, were not included, the observed complex 
4. Discussion 
76 
 
represents most probably a dimerized NEMO dimer (four NEMO molecules x ~50 kDa = ~200 
kDa) reported before by Tegethoff et al. (Tegethoff et al., 2003). The precise composition of the 
NEMO complex as well as the specific consequences of disulfide linkage for NEMO function 
and interactions with its numerous binding partners will be investigated in future studies. 
4.5.3 Up- and downstream processes of NEMO 
Expression of a constitutively active mutant of IKKβ (Mercurio et al., 1997) that supersedes 
NEMO regulation of IKK complex activation completely rescued pro-inflammatory signaling in 
macrophages deficient for ROS in general or mtROS in particular. These data demonstrate that 
ROS deficiency does not affect processes downstream of IKK complex activation. Processes 
directly upstream of IKK complex activation such as IRAK1 degradation were also not impaired 
by ROS deficiency. 
Thus, my data specifically introduce the mtROS-mediated disulfide linkage of NEMO as an 
essential regulatory step required for activation of the IKK complex and, thereby, for permitting 
ERK1/2 and NF-κB signaling leading to pro-inflammatory cytokine secretion in infected 
macrophages. 
4.6 Conclusion 
Collectively, this thesis introduces a so far unknown molecular mechanism by which ROS in 
general and mtROS in particular regulate pro-inflammatory cytokine secretion in infected 
macrophages and identifies covalent disulfide linkage of NEMO via Cys54/347 by mtROS as a 
novel regulatory step critically required for activation of the IKK complex and subsequent 
signaling via the ERK1/2 and NF-κB pathways. 
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6. Summary 
A major function of macrophages during infection is the initiation of the pro-inflammatory 
response leading to secretion of cytokines that help to orchestrate the immune response. 
Reactive oxygen species (ROS) produced by NADPH oxidases, such as Nox2, and by 
mitochondria are key components of host cell defense against invading microbial pathogens. 
However, nearly nothing is known about the role of ROS in general or mitochondrial ROS 
(mtROS) in particular during pro-inflammatory signaling in infected macrophages. Moreover, the 
underlying molecular mechanisms by which mtROS may regulate pro-inflammatory signaling 
and cytokine secretion upon bacterial infection have remained completely elusive. 
In this thesis, I delineate ROS as crucial regulators of pro-inflammatory signaling and cytokine 
secretion in Listeria monocytogenes (L.m.)-infected macrophages. Surprisingly, my data show 
that the ROS, which license pro-inflammatory signaling, are produced, in fact, by mitochondria 
(mtROS). Infection of macrophages triggers O2
- production into the mitochondrial 
intermembrane space (IMS) by complex III of the ETC initiated via the TLR2/MyD88/TRAF6 
signaling pathway. In the IMS O2
- is converted by superoxide dismutase (SOD1) into H2O2 that 
diffuses into the cytosol where it regulates secretion of pro-inflammatory cytokines. 
Mechanistically, I identify the regulatory IKK complex subunit NEMO as the molecular target for 
mtROS. Specifically, the redox-dependent intermolecular covalent linkage of NEMO via 
disulfide bonds formed by Cys54 and Cys347 is the underlying molecular mechanism by which 
mtROS license full activation of the IKK complex and subsequent signaling via the ERK1/2 and 
NF-κB pathways that eventually lead to secretion of pro-inflammatory cytokines. 
Taken together, this thesis introduces mtROS-dependent disulfide linkage of NEMO as a so far 
unknown novel regulatory step critically required for the pro-inflammatory response of infected 
macrophages. 
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7. Zusammenfassung 
Eine wichtige Aufgabe von Makrophagen während einer Infektion ist die Koordination der 
Immunantwort. Dafür notwendig ist die Initiierung einer pro-inflammatorischen Signalkaskade, 
die zur Sekretion von Zytokinen führt. Reaktive Sauerstoffspezies (ROS), welche in 
Makrophagen vor allem durch die die Phagozyten-Oxidase Nox2 und durch Mitochondrien 
produziert werden, sind zentrale Komponenten der Abwehr gegen Pathogene. Es ist jedoch 
noch gänzlich unbekannt, ob und wie ROS pro-inflammatorische Signalwege in infizierten 
Makrophagen steuern. 
In dieser Doktorarbeit identifiziere ich, anhand von mit Listeria monocytogenes infizierten 
Makrophagen, ROS als notwendige Regulatoren des zur Sekretion von Zytokinen führenden 
pro-inflammatorischen Signalwegs. Überraschenderweise zeigen meine Daten, dass die für die 
Regulation der pro-inflammatorischen Signalkaskade verantwortlichen ROS nicht durch Nox2, 
sondern von Mitochondrien (mtROS) produziert werden. Stimuliert über TLR2 und andere 
MyD88- und TRAF6 abhängige Rezeptoren produziert Komplex III der mitochondrialen 
Atmungskette vermehrt Superoxid in den Intermembranraum. Dort wird es mittels der 
Superoxid-Dismutase 1 (SOD1) zu Wasserstoffperoxid umgewandelt, welches, nach seiner 
Diffusion ins Zytosol, die zur Sekretion von Zytokinen führende pro-inflammatorische 
Signalkaskade reguliert. 
Auf mechanistischer Ebene habe ich die regulatorische Untereinheit des IKK-Komplex, 
NEMO/IKKγ, als Zielmolekül der mtROS identifiziert. Durch mtROS werden NEMO Moleküle 
über Disulfidbrücken zwischen den beiden redox-sensitiven Cysteinresten Cys54 und Cys 347 
kovalent miteinander verknüpft. Diese Verknüpfung ist für die vollständige Aktivierung des IKK-
Komplex und die nachfolgende Aktivierung der MAP-Kinase ERK1/2 und des 
Transkriptionsfaktors NF-κB, welche notwendig für die Sekretion von pro-inflammatorischen 
Zytokinen sind, von großer Bedeutung. 
Zusammenfassend deckt diese Doktorarbeit, mit der mtROS-abhängigen kovalenten 
Verknüpfung von NEMO über Disulfidbrücken, einen bisher unbekannten kritischen 
regulatorischen Schritt des zur Sekretion von pro-inflammatorischen Zytokinen durch infizierte 
Makrophagen führenden Signalweges auf. 
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